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ABSTRACT
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting
birds in the southeastern United States. The cause of the disease has not yet been
determined but is believed to be a naturally produced toxin and is associated with
aquatic vegetation. Current research on AVM is limited to in vivo studies
utilizing whole tissue or vegetative samples. The objectives of this research were
to develop extraction methods for isolating the putative AVM toxin from
vegetative samples and to develop an in vitro bioassay for detection and study of
the toxin. Samples of vegetation were collected from reservoirs known to be
affected by AVM and confirmed to contain the toxin by mallard bioassay. The
collected vegetation was then extracted with a series of solvents and the crude
extracts were re-introduced to a mallard model to confirm the presence or absence
of the AVM agent. All birds administered a methanol extract developed
characteristic AVM lesions, indicating that methanol is a suitable solvent for
AVM toxin extraction. Additional crude extracts were produced from vegetation
collected at AVM-affected reservoirs as well as reservoirs with no known history
of AVM and evaluated for their in vitro toxicity using established cell lines.
Extracts produced from vegetation collected at AVM sites induced a significant
cell cycle arrest in C6 glioma cells, while AVM-negative extracts induced only
mild effects on this endpoint. To further evaluate this in vitro assay for its ability
to detect the AVM toxin, as well as continue the development of toxin extraction

methods, fractions were produced from a crude methanol extract and evaluated
for toxicity by the cell cycle assay as well as an in vivo chicken bioassay. The
fractionation methods were successful in isolating the in vitro toxicity, but the
presence of the AVM toxin could not be confirmed in these fractions due to
inconclusive in vivo results. Further testing will be necessary to determine if the
observed cell cycle arrest is due to the etiologic agent of AVM as well as to
advance the process of AVM toxin isolation and characterization, but this
research has providing promising tools for future AVM investigations.
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PREFACE
This dissertation was written in journal style and organized into five
chapters, preceded by a general introduction and followed by a conclusions
section. The chapters represent different research projects and each is comprised
of introduction, materials and methods, results, discussion, and literature cited
sections. Each chapter is intended for separate publication; therefore, repetition is
present in some sections.

INTRODUCTION
Avian vacuolar myelinopathy (AVM) is a neurological disease primarily
affecting bald eagles (Haliaeetus leucocephalus) and American coots (Fulica
americana) in the southeastern U.S. AVM was first observed during the winter of
1994-1995 and has been documented in five states: Arkansas, Georgia, North
Carolina, South Carolina, and Texas. Since 1994, AVM has been responsible for
the deaths of over 100 bald eagles and estimates of over a thousand coots. Despite
extensive investigations, the cause of AVM remains unknown, though all
information gathered to date suggests a toxin, most likely of natural origin.
AVM is characterized and diagnosed by a spongy degeneration of the
white matter of the central nervous system (CNS). Multiple vacuoles of varying
severity are seen throughout the white matter of the brain and spinal cord, being
particularly prominent in the optic tectum (Thomas et al., 1998). Birds with AVM
may display clinical signs of neurological impairment, including difficulty in
swimming, flying, and/or walking. Not all birds with AVM lesions display these
signs, and clinical recovery has been documented despite the persistence of
lesions (Larsen et al., 2002).
The first documented cases of AVM occurred during the winter of 19941995 at DeGray Lake, Arkansas, USA (Thomas et al., 1998). During this event,
29 bald eagles were found either dead or dying, and those still alive displayed
signs of neurological impairment. Two winters later, 26 eagles died at DeGray
Lake and nearby Lakes Ouachita and Hamilton. Wintering American coots were

observed with similar signs of impairment during both of these events, though
only a small number were found dead. Thorough diagnostic evaluations of eagles
and coots were conducted by the National Wildlife Health Center, Madison,
Wisconsin, USA. No consistent gross abnormalities were seen and no infectious
disease agents were discovered. In addition, no significant concentrations of any
toxins or toxicants were detected. The only consistent finding was the presence of
microscopic vacuoles throughout the white matter of the CNS. Electron
microscopy confirmed the vacuoles were formed by separation of the myelin
lamellae at the intraperiod line, a condition known as intramyelinic edema
(Thomas et al., 1998). This condition can be caused by several known chemicals,
including triethyltin, hexachlorophene, bromethalin, and others, though none of
these compounds were detected in tissues.
AVM was first documented outside of Arkansas during the winter of
1997-1998, when affected coots were observed at Woodlake (Lake Surf), North
Carolina and Lake Juliette, Georgia. The following winter, additional affected
coots were observed at these sites, as well as at Lake Ouachita, Arkansas and
three sites in South Carolina: Lake Murray, J. Strom Thurmond Lake (JSTL), and
Par Pond, a reservoir at the Savannah River Site (SRS). In addition, Lake Juliette,
Woodlake, JSTL, and SRS each had one eagle mortality. AVM was first
documented in waterfowl during the winter of 1998-1999, with a low incidence of
AVM in mallards (Anas platyrhynchos), ring-necked ducks (Aythya collari), and
buffleheads (Bucephala albeola) at Woodlake (Augspurger et al., 2003). The
largest eagle mortality events outside of Arkansas occurred at JSTL during the
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winters of 2000-2001 and 2001-2002, during which 23 eagles died. Several more
species have also been documented with AVM, including Canada geese (Branta
canadensis), great-horned owl (Bubo virginianus), and killdeer (Charadrius
vociferus) (Fischer et al., 2002).
In recent years, eagle mortalities continue to be observed and AVMpositive coots are observed each year at sites where active monitoring is
conducted (Fischer et al., 2006). In addition, several more sites of AVM
mortalities have been documented in recent years, including several small
residential ponds in Georgia and North Carolina, and a small farm pond in South
Carolina (Wilde et al., 2005; Fischer, unpubl. data). These sites demonstrate that
AVM is not restricted to large reservoirs and may be undetected in smaller
systems.
While the cause of AVM remains elusive, evidence gathered to date
suggests a toxin of natural origin. The lack of inflammatory response in tissues
and inability to detect any infectious disease agents makes the probability of a
bacterial or viral infection very low. In addition, the disease has not been shown
to be transmissible by direct contact with affected birds (Larsen et al., 2003). The
pathology of AVM suggests an acutely toxic compound, since the lesions
manifest quickly without any systemic involvement (Thomas et al., 1998). The
nature of AVM epornitics also indicates a toxin as the source of disease. Rocke et
al. (2002) conducted a sentinel study in which healthy coots and mallards were
released over a four-year period onto Woodlake. Results showed that AVM is
site-specific, can have a quick time of onset (as early as 5 days post-release), and
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is seasonal, with AVM events occurring during the late fall to early winter and
lasting up to several months.
The search for the toxic agent has proven challenging. As mentioned,
extensive toxicological tests were conducted on coot and eagle tissues during the
first AVM epizootics (Thomas et al., 1998). Various tissues were analyzed for a
wide spectrum of organic and inorganic compounds, but no significant
concentrations were detected. In a separate study, coot tissues and sediments
from AVM reservoirs and control sites were analyzed for lipophilic organic
compounds in hopes of finding a compound unique to AVM sites (Dodder et al.,
2003). Despite the presence of detectable contaminants, no compound could be
singled out as a probable suspect.
Although the causative agent has not yet been discovered, it is now
evident that AVM is acquired orally, through consumption of affected food items.
In the first study to reproduce AVM in the laboratory, Fischer et al. (2003)
demonstrated transmission from AVM-affected coot tissue to red-tailed hawks
(Buteo jamaicensis), establishing the link between coots and eagles in the wild.
During coot migrations, which generally coincide with AVM epornitics, these
water birds are a major food source for bald eagles.
With evidence that AVM is acquired by ingestion, the food sources of
coots in these reservoirs became a focus of research. All known AVM reservoirs
contain one or more of the exotic aquatic plants hydrilla (Hydrilla verticillata),
Brazilian elodea (Egeria densa), or Eurasian watermilfoil (Myriophyllum
spicatum). These species cover extensive acreage in the reservoirs and serve as
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the major food item of wintering coots. The first study to attempt induction of
AVM in waterfowl through ingestion of this aquatic vegetation was unsuccessful.
In that study, mallards were orally gavaged with hydrilla from an AVM reservoir
for seven days (Larsen et al., 2003). Sediment and water from the same reservoir
were also examined as potential sources. No mallards developed lesions, though
the authors suggest that exposure duration and quantity of material consumed may
have been inadequate to induce the disease, or the vegetation could have been
collected at a time when the AVM agent was not present.
Three independent studies have now confirmed that coots and waterfowl
do acquire AVM though ingestion of aquatic vegetation. These studies induced
AVM in mallards and domestic chickens (Gallus domesticus) by ingestion of
hydrilla and associated materials collected from JSTL during an AVM epizootic
(Birrenkott, 2003; Birrenkott et al., 2004; Lewis-Weis et al., 2004; Rocke et al.
2005). The studies allowed the birds to feed ad libitum, with exposures ranging
from 23 days to seven weeks. Hydrilla does not appear to be the causative agent
of AVM, as it does not occur at all AVM sites and it is found in other areas where
AVM has not been documented. It is thought, rather, that something associated
with aquatic vegetation may be the cause.
Hydrilla collected from JSTL that induced AVM in the mallard laboratory
study (Birrenkott et al., 2004) contained large quantities of a novel cyanobacteria
species. Colonies of this species, a previously uncharacterized member of the
Order Stigonematales (Williams et al., 2007), covered 50-90% of the leaf surface
of the hydrilla (Birrenkott et al., 2004). Surveys of cyanobacterial epiphytes
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revealed the consistent presence of this Stigonematalan species at all known sites
of AVM epizootics (Wilde et al., 2005). The species was also found at a few sites
where AVM has not been documented, though the relative abundance at these
sites was significantly less than sites of AVM epornitics (Wilde et al., 2005).
Researchers have postulated that this species produces a toxin responsible for
AVM. The novel Stigonematalan species has been successfully cultured in the
laboratory and genetic and physiological analyses have begun (Habrun, 2004). A
preliminary feeding trial in which Stigonematalan cultures were fed by gavage to
American coots produced no definitive lesions in the treatment birds (Wilde,
unpubl. data). This does not disprove the hypothesis that the cyanobacteria are
the producer of the toxin. The cyanobacterial cultures may not have been actively
producing the toxin at the time of feeding, or the birds may not have been exposed
to sufficient concentrations for the disease to develop. Cultures of the
cyanobacteria are currently being grown under differing nutrient and temperature
regimes, and these cultures will be used in future feeding trials.
Much research is still needed in the study of AVM, in addition to
determining the cause and source of the disease. The pathology, range of
susceptible species, implications for wildlife populations, and management
strategies all need to be further explored. Areas of potential research on the
pathology of AVM include mechanism of action, exposure time and concentration
necessary to produce the disease, possibility of recovery, and acute versus chronic
exposure effects. It is unknown why some birds develop clinical neurological
signs and others do not. Clinical recovery has been shown in coots after being
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taken into captivity, though lesions were still present upon necropsy 65 days later
(Larsen et al., 2002). It is unknown whether or not the lesions can heal. In
addition, there have been several reports of birds displaying clinical signs
consistent with AVM without the presence of lesions upon necropsy (Lewis-Weis
et al., 2004; Rocke et al., 2005).
The list of species known to be susceptible to AVM is currently confined
to birds, but susceptibility of other classes of organisms should be further
explored. Lesions have never been confirmed in mammals during AVM
epizootics, though there has been anecdotal evidence of possible clinical signs in
a beaver (Castor canadensis) (Lewis-Weis et al., 2004). Histological analysis of
brains from beavers, raccoons (Procyon lotor), and a gray fox (Urocyon
cinereoargenteus) collected at J. Strom Thurmond Lake revealed no
abnormalities, despite the presence of coot tissues in the intestinal contents of one
raccoon and the fox (Fischer et al., 2006). Swine failed to develop lesions when
fed AVM-affected coot tissue in a laboratory study, though the authors
acknowledge that the duration of exposure and quantity of ingested material
should be explored further before concluding that mammals are not susceptible
(Lewis-Weis et al., 2004). Mice fed hydrilla collected during AVM events also
failed to develop lesions (Rocke et al., 2005; Birrenkott, unpubl. data); however,
these animals did not appear to consume much, if any, of the vegetation in one
study (Birrenkott, unpubl. data). It is also possible that the vegetation did not
contain the causative agent in sufficient quantity to induce disease.

9

The impact of AVM to wildlife populations is largely unknown.
Birrenkott (2003) examined the impact of AVM on South Carolina and Georgia’s
bald eagle population, concluding that AVM has significantly affected local
populations. Since eagles in these states are non-migratory and their breeding
seasons coincide with AVM epizootics, AVM could pose a significant risk to
statewide populations if it should spread to other reservoirs. Impacts to coot and
waterfowl populations are beginning to be explored.
Management of AVM epizootics is also an area that needs to be further
addressed. Considerations for management will ultimately depend upon
determination of the source of the disease. However, the knowledge that AVM is
associated with aquatic vegetation, in particular invasive plants, has given
researchers and managers an area of focus. Exotic aquatic weeds have been
impacting the nation’s waterways since the late 1800s, and management of these
plants is still a major area of research today (Cofrancesco, 1998). Various
mechanical, chemical, and biological control methods have been used, with
varying degrees of success. Biological control, which involves the introduction
and release of exotic insects, predators, or pathogens, is presently the predominant
method of weed control and subject of much current research (McFayden, 1998).
The knowledge that AVM is associated with noxious weeds adds an additional
factor of consideration for aquatic plant managers working in AVM reservoirs.
Researchers are currently studying sterile grass carp (Ctenopharyngodon idella)
as a potential hydrilla control agent in AVM reservoirs. Grass carp have been
used to control aquatic weeds in the U.S. since the 1960s, with much success
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(Masser, 2002). Current research is focused on whether or not carp are affected by
the AVM toxin, and whether they could be a potential vector of the disease to
predators. Similar considerations and study should be made with other weed
control agents currently used in reservoirs where AVM has been documented.
The purpose of my research was to examine the putative toxin responsible
for AVM and it consists of two major objectives. The first objective was to
develop an extraction procedure for isolating the toxin from its environmental
matrix, i.e. aquatic vegetation and associated epiphytes. Without an extraction
procedure, AVM researchers are limited to in vivo studies involving whole tissue
or vegetative samples. While such studies can be useful, they are limited in terms
of the information they can provide. Research on toxin chemistry, and eventually
toxin isolation and identification, necessitates the isolation of the putative toxin
from the environmental matrix. This involved first obtaining vegetation known to
contain the toxin (Chapter 1) then developing and testing crude extracts produced
from this material (Chapter 2). Once a suitable method was developed for
extracting the AVM toxin from vegetation, further fractionation of the crude
extract was conducted in an attempt to produce a more purified extract (Chapter
4).
The second major objective of this research was to develop an in vitro,
cell-based assay for detection of the AVM toxin. An in vitro model will allow for
rapid and sensitive detection of the toxin and can thus be used to guide toxin
fractionation and isolation studies. In addition, such assays can be used to study
the biochemistry and pathology of the toxin. Established cell lines were exposed
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to extracts produced from both AVM-positive and AVM-negative hydrilla and
toxicity was assessed by examining several endpoints, including cytotoxicity,
mechanism of cell death (apoptosis v. necrosis), morphological and cytoskeletal
changes, and cell cycle disruption (Chapter 3). Cell cycle disruption was
observed in one cell line and this assay was then used to track toxicity in the
extract fractions produced in Chapter 4.
In addition to the two main objectives, mammalian susceptibility was
explored using a mouse model (Chapter 5). Mice were exposed to the confirmed
AVM-positive extracts produced in Chapter 2 by oral gavage, providing a better
assessment of AVM susceptibility than previous mammalian toxicity studies.
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CHAPTER 1
INVESTIGATION OF THE LINK BETWEEN AVIAN VACUOLAR
MYELINOPATHY AND A NOVEL SPECIES OF CYANOBACTERIA
THROUGH LABORATORY FEEDING TRIALS

Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting
bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana), and
other birds in the southeastern U.S. First observed in 1994, the cause of AVM
remains elusive despite extensive investigation, although the pathology of the
disease and epizootiologic studies suggest a toxin (Thomas et al., 1998; Rocke et
al., 2002).
AVM is characterized by microscopic vacuolization of the white matter of
the central nervous system, resulting from a separation of the myelin lamellae at
the intraperiod line (Thomas et al., 1998). This pathology is consistent with
intramyelinic edema, a condition that can be caused by several known
compounds, including triethyltin, hexachlorophene, and bromethalin (van Gemert
and Killeen, 1998). No significant concentrations of any of these compounds or
various other environmental contaminants have been detected in tissues or
environmental samples from AVM mortality events. In addition, there has been
no evidence to link AVM to infectious agents (Thomas et al., 1998; Larsen et al.,
2003).

Epidemiological investigations and sentinel studies have established that
AVM is site-specific, seasonal in occurrence, and can have a rapid onset (Rocke
et al., 2002). AVM generally occurs during late fall and early winter and the
onset of disease can occur as quickly as five days after exposure to the causative
agent. In addition to bald eagles and American coots, several other avian species
have been diagnosed with AVM, including mallards (Anas platyrhynchos), ringnecked ducks (Aythya collaris), buffleheads (Bucephala albeola), Canada geese
(Branta canadensis), great-horned owls (Bubo virginianus), and a killdeer
(Charadrius vociferus) (Fischer et al., 2002; Augspurger et al., 2003). Birds with
AVM may display clinical signs, including difficulty or inability to walk, swim,
and/or fly and general ataxia. Not all birds with AVM lesions display these signs,
thus microscopic evaluation of brain tissue is necessary for diagnosis.
Recent studies have established that AVM is acquired through ingestion
and transferred through the food chain. Transfer of AVM from water birds to
raptors was demonstrated when captive red-tailed hawks (Buteo jamaicensis)
developed AVM after ingesting AVM-affected coot tissue in the laboratory
(Fischer et al., 2003). AVM was experimentally induced in both mallards and
domestic chickens (Gallus domesticus) through ingestion of aquatic vegetation
(Hydrilla verticillata and associated materials) from AVM affected reservoirs
(Birrenkott et al., 2004; Lewis-Weis et al., 2004).
Researchers are now examining a possible link between AVM and a
species of cyanobacteria associated with the aquatic vegetation. Surveys of
epiphytic algal communities revealed the presence of a novel species of
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cyanobacteria at all confirmed AVM sites (Wilde et al., 2005). This species, a
previously undescribed member of the order Stigonematales, was the dominant
epiphyte during the AVM season in those water bodies where AVM has been
observed most frequently and was the dominant epiphyte associated with hydrilla
that induced AVM in laboratory mallards (Birrenkott et al., 2004). One hypothesis
is that the etiologic agent of AVM is a neurotoxin produced by this
cyanobacterium. The purpose of this study was to further examine the
relationship between the Stigonematalan species and AVM induction, using
animal feeding trials. In two separate trials, we attempted to induce AVM in
animal models by feeding aquatic vegetation containing large quantities of the
Stigonematalan species. Control animals received vegetation of the same type
that did not contain the Stigonematalan species. In addition, we attempted to
examine the time period necessary to induce AVM in the laboratory and were
able to further explore the temporality of AVM occurrence.

Materials and Methods
Study Area
Aquatic vegetation (Hydrilla verticillata and associated materials) was
collected from three sites in South Carolina (SC). Hydrilla containing the
Stigonematalan species was collected from J. Strom Thurmond Lake (JSTL)
(34 40’40’’ N, 82 13’0’’ W) and Davis Pond (33 42’23”N, 82 08’15”W). JSTL is
a 28,700 ha reservoir located on the Savannah River on the border of South
Carolina and Georgia and is a site of previous AVM epornitics. For this study,
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hydrilla was collected from the Parksville Recreation Area, located along the
southeast region of the lake. The Stigonematalan species was the most prevalent
epiphyte associated with the hydrilla. Davis Pond is a 1.6 ha private pond located
6.8 km east of JSTL. The pond had been colonized by hydrilla during the summer
of 2003 and no AVM morbidity or mortality had been observed previously at this
site. At the time of the study, the Stigonematalan species was determined to be
the most prevalent epiphytic species.
Control hydrilla was collected from Lake Marion, SC (33 32’18”N, 80
16’05”W), a 44,500 ha reservoir with no known AVM morbidity or mortality.
Hydrilla was collected from the Potato Creek Embayment area. This site was
chosen because it contained an abundance of hydrilla and associated epiphytes,
but contained no observable colonies of the suspect Stigonematalan
cyanobacteria. American coots were also collected from this site and analyzed
for AVM lesions to ensure that the disease was not present.

Trial I
Mallard ducks and domestic chickens served as animal models. Sixteen
adult male mallards were purchased from Whistling Wings (Hanover, Illinois,
USA) and sixteen adult female chickens were obtained from the Clemson
University Morgan Poultry Center (Clemson, South Carolina, USA). All birds
were obtained 14 October 2003 and were housed in Godley-Snell Research
Center at Clemson University. Both species were randomly divided into two
experimental groups, treatment and control, with eight birds in each group.
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Animals were housed according to experimental group. Treatment birds were fed
hydrilla from JSTL and control birds were fed hydrilla from Lake Marion.
Hydrilla was collected from Lake Marion 14 October 2003 and from JSTL
7 October 2003. Hydrilla was collected with a rake from depths of up to 1.5 m
and transported in covered plastic containers. A sub-sample from each site was
examined microscopically to determine the associated epiphytes. Three random
entire leaves were mounted on a glass slide and the average surface area covered
by the cyanobacterial epiphytes was measured using epifluorescence microscopy.
Surface area coverage was classified into four categories: present (1-25%),
common (26-50%), abundant (51-75%), or dominant (76-100%). Real-time PCR
was also performed to genetically confirm the presence and abundance of the
Stigonematalan species (Williams et al., 2007), as described below. All collected
vegetation was frozen at -20°C. Half of the hydrilla was distributed into gallonsize plastic bags before freezing for use in the feeding trials and the remaining
half was stored at -20°C for potential future toxin analysis. Administration of
hydrilla began 15 October 2003. All hydrilla was thawed before feeding. For
mallards, hydrilla was given twice daily and placed in swim tanks for birds to
consume ad libitum. Each group of mallards (n=8) received approximately 1000 1700 g wet weight (ww), although this measurement includes a substantial
amount of water so the actual mass of hydrilla would be much less. Chickens
received hydrilla twice daily as well, placed in feeding trays. Each group of
chickens (n=8) received approximately 500-1200 g ww daily. All birds were
given progressively less hydrilla as the number of birds per experimental group
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was reduced each week, as described below. Both species received supplemental
commercial feed for one hour twice daily and water was available ad libitum.
Behavior was observed twice daily and weights were recorded twice weekly.
Following the first week of feeding, one-fourth of the birds (two treatment
and two control of both species) were sacrificed each week, with the last group of
birds receiving hydrilla for four weeks. Birds were euthanized by CO2 and whole
brains were removed. Brains were placed in 10% neutral buffered formalin and
transported to the Southeastern Cooperative Wildlife Disease Study (SCWDS,
Athens, Georgia, USA) for analysis.

Trial II
Trial II was conducted 18 November – 17 December 2003. Eighteen adult
male mallard ducks were received from Whistling Wings 18 November. Mallards
were housed at Godley-Snell Research Center according to experimental group.
The study sites for this trial included JSTL, Davis Pond, and Lake Marion.
Hydrilla was collected weekly at each site during the course of the study,
beginning 18 November. Sub-samples of hydrilla were examined for epiphytes as
in Trial I. Quantitative real-time PCR was performed on select samples.
Collection methods were identical to Trial I, with the exception that half of the
hydrilla used in the feeding trials was kept at room temperature while the other
half was frozen, and subsequently thawed, prior to feeding. This was done to
determine if freezing the hydrilla had an impact on viability of the etiologic agent.
Therefore, birds were randomly divided into six experimental groups, with three
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birds per group: 1) JSTL, frozen hydrilla; 2) JSTL, fresh hydrilla (kept at room
temperature); 3) Davis Pond, frozen hydrilla; 4) Davis Pond, fresh hydrilla; 5)
Lake Marion, frozen hydrilla; and 6) Lake Marion, fresh hydrilla. Feeding
methods were the same as in Trial I, with birds receiving hydrilla twice daily.
Each group of birds (n=3) received approximately 500 to 1200 g ww daily.
Behavior was observed twice daily and weights were recorded twice weekly. Due
to the smaller experimental groups (n=3) in Trial II, all birds were sacrificed after
four weeks of feeding. However, two birds were euthanized prior to this date
after developing signs of neurological impairment. Methods of euthanasia and
brain analysis were the same as in Trial I.

Real-time PCR Analysis
Real-time PCR analysis was conducted using methods developed by
Williams et al. (2007). From each environmental location tested, 0.5 g of hydrilla
leaves were weighed. DNA for real-time PCR was extracted using the
UltraCleanTM Plant DNA Isolation Kit (Mo Bio Laboratories, Inc., Carlsbad,
California, USA) following the kit protocol. All real-time PCR assays were
conducted using the SmartCyler® System (Cepheid, Sunnyvale, California,
USA). Reaction protocols for each assay consisted of three stages: two
denaturation stages at 96°C for 75 s, 45 cycles at 96°C for 5 s, and an annealing
stage at 58°C for 40 s. Reaction mixtures from each assay consisted of two
flanking primers and an internal fluorescent-labeled probe developed by Williams
et al. (2007) (Stig 1069 forward primer, primer sequence
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5'-AGGGTGGGCACTCTAAAGA-3'; Stig 1248 reverse primer, primer sequence
5'-CAGCCTTCGATCTGAATTG-3'; Stig 1209 probe, sequence
5'[6~FAM]CAAATCTCGTAAACCGTTGCTAATT[TAMRA~6~FAM]3').
The following reagents were added to each 25 Vl reaction mixture: 0.2 Vm
primers and internal probe; 1 x PCR buffer (Promega, Madison, Wisconsin,
USA), 2.5 mM MgCl2, 0.2 mM dNTP mixture (Stratagene, La Jolla, California,
USA), 10 VM bovine serum albumin, and 0.2 U Vl-1 Taq polymerase (Promega,
Madison, Wisconsin, USA).

Results
Trial I
In Trial I, no birds developed any clinical signs of AVM and all brains
were negative for AVM lesions. Mallard body weights remained relatively
constant over the course of the study, with an average increase of 6.1% (± 8.0%
[SD]) and no individual weight loss exceeding 3.0%. Mallards readily ate the
vegetation, consuming almost all of the offered material. The chickens consumed
much less material than the ducks, only consuming one-third to one-half of the
material offered and had an average weight loss of 5.4% (± 5.6%) from the
beginning of the trial to euthanasia. No individual weight loss exceeded 20%.
Cyanobacterial epiphytes associated with the vegetation collected for Trial
I, and their relative abundance, are shown in Tables 1 and 2. Several genera were
present on both Lake Marion and JSTL material, with the Stigonematalan species
dominant on JSTL vegetation and absent from Lake Marion vegetation. Real-

22

time PCR confirmed the absence of Stigonematalan colonies on Lake Marion
material, and reported a value of 577.96 cells/ml for JSTL material.

Trial II
In Trial II, two birds developed signs of neurological impairment
consistent with AVM. On the afternoon of 23 November, five days after
initiation of the study, a member of the JSTL Fresh group was observed leaning
backwards with a slightly unsteady gait. The bird was still eating and drinking
readily. On the morning of 24 November, the bird displayed more severe ataxia,
including falling onto its side and backwards, and inability to walk properly. At
this time, the bird was euthanized and the brain was placed in formalin.
On 1 December, thirteen days after initiation of the study, another member
of the JSTL Fresh group developed clinical signs consistent with AVM. This bird
was observed tilting forward and generally appeared off balance and lethargic.
The bird was euthanized and the brain was stored in formalin.
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Table 1. Percent leaf surface area coverage of cyanobacterial epiphytes on
collected vegetation (Hydrilla verticillata). Coverage was based on microscopic
analysis of three random entire leaves and classified as either present (1-25%),
common (26-50%), abundant (51-75%), or dominant (76-100%).

Trial Ia

Trial IIb

Cyanobacterial
Genus

Lake
Marion

JSTLc

Anabaena
Aphanothece
Gloeotrichia
Gomphosphaeria
Leptolyngbya
Microcoleus
Oscillatoria
Phormidium
Pseudanabaena
Spirulina
Stigonematales sp.
Trichormus

Present
Present
Abundant

Present
Present

a

Lake Marion

Present
Common
Present
Common
Present

Common

Davis Pond

Present
Present

Present

Present
Present

Present

Present

Present

Present
Present
Present

Present
Common

JSTL

Abundant
Present

Present
Dominant

Common

Abundant
Present

Vegetation collected 7 October 2003 for JSTL, 14 October 2003 for Lake

Marion.
b

Vegetation collected 18 November 2003. See Table 2 for Stigonematales

coverage on additional collection dates.
c

J. Strom Thurmond Lake
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Table 2. Percent leaf surface area coverage of the Stigonematales species on
collected vegetation (Hydrilla verticillata). Coverage was based on microscopic
analysis of three random entire leaves and classified as either present (1-25%),
common (26-50%), abundant (51-75%), dominant (76-100%), or ND (not
detected). Quantitative real-time PCR performed on select samples is listed in
parentheses below coverage.

Trial I
7 October

Lake Marion

JSTLa

Davis Pond

-----------b

-----------

Abundant
(162.59 cells/ml)
Abundant

14 October

ND

Abundant
(577.96 cells/ml)
-----------

Trial II
18 November

ND

Dominant

25 November

ND

Abundant

2 December

ND

9 December

ND

Abundant
(345.46 cells/ml)
Abundant

a

J. Strom Thurmond Lake

b

No collection at this site
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-----------

Common
Common

All other birds in Trial II remained clinically normal during the study. All
weights remained relatively constant, with an average weight gain of 6.8% (±
11.5%) over the course of the study and no individual weight loss greater than
8.0%. The birds readily consumed the majority of the vegetation offered.
Microscopic examination of brain tissue revealed the presence of AVM lesions in
ten mallards, including the two displaying clinical signs. All six of the birds
receiving JSTL hydrilla developed AVM, and four of the six birds receiving
hydrilla from Davis Pond developed the disease (two out of three birds in both the
Davis Fresh and Davis Frozen groups). No AVM lesions were observed in any
bird receiving hydrilla from Lake Marion.
Cyanobacterial epiphytes associated with vegetation collected for Trial II
are shown in Tables 1 and 2. The Stigonematalan species was not observed on
Lake Marion material, though several other cyanobacterial genera were present.
Leaf coverage of the Stigonematalan species on JSTL hydrilla was classified as
abundant to dominant (51-100% leaf coverage), and quantitative real-time PCR
on the 2 December 2003 collection reported a value of 345.46 cells/ml. Leaf
coverage for Davis Pond was classified as common to abundant (26 -75% leaf
coverage), and quantitative real-time PCR on the 18 November 2003 collection
reported a value of 162.59 cell/ml.

Discussion
No birds in Trial I contracted AVM, apparently due to the absence or
insufficient concentration of the causative agent in the collected vegetation. At
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the time there was concern about whether or not freezing the material would
affect the viability of the AVM agent, but results from Trial II have demonstrated
that freezing did not have an effect, which is consistent with previous studies
(Fischer et al., 2003; Lewis-Weis et al., 2004). Despite being housed in larger
groups, ducks in Trial I had access to approximately the same amount of hydrilla
as those in Trial II, and all birds appeared to eat readily. The chickens however,
consumed much less hydrilla than the mallards and were therefore not used in
Trial II. Chickens have been shown to be susceptible to AVM and an acceptable
animal model for vegetation feeding trials in another study (Lewis-Weis et al.,
2004).
Ten of twelve treatment ducks in Trial II were diagnosed with AVM
lesions, indicating that at least some vegetative samples from both JSTL and
Davis Pond collected during November and December contained the causative
agent in sufficient quantity to produce lesions. The hydrilla collected from JSTL
during the week of November 18 certainly contained the etiologic agent, as the
bird that displayed clinical signs at five days had only consumed material from
this collection.
Hydrilla was collected from the same site at JSTL for both trials; however,
only that material collected during the second trial, collected November 18 December 9, induced AVM, while material collected in October did not. The lack
of AVM induction with earlier collections is consistent with other observations of
AVM seasonality. Previous studies have reported the occurrence of AVM from
November through March or April, with the highest prevalence in November and
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December (Rocke et al., 2002; Fischer et al., 2002). On JSTL specifically, the
majority of diagnostic accessions submitted to SCWDS since 1998 were found
November – January, although active surveillance of coots on JSTL from 19982004 revealed the presence of lesions from October to March (Fischer et al.,
2006). At the time of our collections in 2003, active surveillance of coots
revealed no prevalence of lesions in October, but lesions were present in 22%
and 7% of coots collected in November and December, respectively (Fischer et
al., 2006). This marked seasonality supports the idea that AVM is the result of a
naturally produced toxin.
Factors that initiate toxin production in cyanobacteria and other algal
species are not precisely known (Haider et al., 2003). Toxins are usually
associated with bloom formation, which can occur in response to environmental
factors such as a change in nutrient concentrations, temperature, or light. In AVM
reservoirs, the suspect Stigonematalan species experiences a bloom beginning late
summer to early fall, occurring in abundance until the vegetation senesces during
the winter months and it loses a suitable substrate (S. B. Wilde, unpubl. data).
Observations of cyanobacterial epiphytes and PCR confirmed the presence of the
Stigonematalan species during both the October and November collections.
Comparable quantities were present for all, except for higher leaf coverage (76100%) for the November 18 JSTL collection than the remaining November
collections and October collection (51-75%).
The fact that the October material did not produce AVM does not imply
that the Stigonematalan species is not involved, only that it may not have been
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actively producing toxin at the time. While changes in algal toxin concentrations
can often be explained by changes in algal abundance, there are many instances
where there is no correlation between numbers of cyanobacteria and toxin
production (Kardinaal and Visser, 2005). The same environmental factors that
influence bloom formation – light, temperature, pH, nutrient ratios and
concentrations – can also influence toxin dynamics. In addition, toxic and nontoxic strains of cyanobacteria can occur within the same species, further
complicating the relationship between cyanobacterial biomass and toxin presence
and concentration (Kardinaal and Visser, 2005).
It was our intention in Trial I to study the time of lesion formation by
feeding our test animals vegetation from a single collection over a one month time
period and euthanizing them at different time points, but no birds developed
visible AVM lesions. However, clinical signs of AVM were observed in one bird
five days after initial exposure to the hydrilla in Trial II. This quick time of onset
has been observed previously with sentinel birds released onto an AVM affected
reservoir (Rocke et al., 2002). It is unclear when the other birds that contracted
AVM in the present study may have developed lesions.
Of the ten birds in the second feeding trial to have confirmed lesions
consistent with AVM, two were observed with clinical signs of the disease. This
frequency is consistent with the previous laboratory trial that successfully
reproduced AVM in mallards, in which one of six ducks with confirmed lesions
displayed clinical signs (Birrenkott et al., 2004). It is not clear why some birds
display clinical signs and others do not. It may be related to the amount of the
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etiologic agent that the bird ingests, the duration of exposure, variation in
individual susceptibility and health of the bird, or some other factor. Lewis-Weis
et al. (2004) reported a higher prevalence of clinical signs in chickens affected
with rickets than in birds of good nutritional status. The mallards developing
clinical signs in this study did not have any obvious signs of impaired health
compared to the other birds, but could have had undetected conditions making
them more susceptible. Thus far there appears to be no correlation between
presence of clinical signs and severity of brain lesions. Birds with severe lesions
can appear clinically normal while those with signs of neurological impairment
can have mild to moderate lesions (Rocke et al., 2002; Fischer et al., 2003).
Regardless of the reason, it is clear that many birds that develop AVM lesions do
not develop clinical signs. This suggests that the disease may go undiagnosed
unless active surveillance is conducted.
While not conclusive, this study provides further evidence that AVM
induction may be linked to a newly discovered cyanobacterial species. At the
least, this novel Stigonematalan species appears to be a good indicator of AVM
disease potential, as material collected from two separate study sites based on the
presence of this species induced AVM. We were able to correctly predict the
presence of the AVM causative agent in Davis Pond due to the existence of two
factors: the abundant submerged aquatic vegetation and the associated abundant
Stigonematalan cyanobacteria. However, since the control and treatment hydrilla
were collected from different study sites, factors other than presence or absence of
the Stigonematalan species may be involved and further study is needed.
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Vegetation collected from the same reservoir, some containing the
Stigonematalan species and some without, would provide more convincing
evidence. However, no reservoirs provided such a situation at the time of our
collections. In addition, due to the nature of the epiphytic growth of
cyanobacteria on the vegetative material, it is impractical, and perhaps not
possible, to separate the cyanobacterial colonies from the vegetation in order to
test it separately.
The Stigonematalan species is currently being cultured in the laboratory
and future experiments include the testing of this material by mallard bioassay. In
addition, experiments are underway involving attempts to extract the putative
AVM toxin from collected vegetation samples. Much research is still needed to
determine the cause of AVM, as well as to provide more information on the
pathology, range of susceptible species, implications for wildlife populations, and
management strategies.
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CHAPTER 2
AN EXTRACT OF HYDRILLA VERTICILLATA AND ASSOCIATED
EPIPHYTES INDUCES AVIAN VACUOLAR MYELINOPATHY IN
LABORATORY MALLARDS

Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting
bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana), and
other birds in the southeastern U.S. First observed in 1994, AVM is responsible
for the deaths of over 100 bald eagles and estimates of over a thousand coots
(Wilde et al., 2005).
AVM is characterized and diagnosed by a spongy degeneration of the
white matter of the central nervous system, specifically an intramyelinic edema
(Thomas et al., 1998). Affected birds may display clinical signs of neurological
impairment, including difficulty in flying, swimming, and/or walking. However,
not all birds with AVM lesions display clinical signs, thus pathological evaluation
of brain tissue is necessary for diagnosis. The pathology of AVM is consistent
with several known chemicals, including triethyltin, hexachlorophene, and
bromethalin (van Gemert and Killeen, 1998), but no significant concentrations of
these or other known toxins have been detected in tissues of affected birds or
environmental samples (Thomas et al., 1998; Dodder et al., 2003). There has also
been no evidence linking AVM to infectious agents and the disease was not found

to be contagious (Thomas et al., 1998; Larsen et al., 2003). Although the etiology
of the disease remains unknown, recent investigations have suggested that the
causative agent for AVM is a cyanobacterial toxin (Birrenkott et al., 2004; Wilde
et al., 2005; Wiley, 2007, Chapter 1).
Previous investigations have established that AVM is site-specific and
seasonal (Rocke et al., 2002), associated with a number of southeastern reservoirs
with epizootics occurring during late fall to early winter. Coots and other
waterfowl contract the disease by feeding on aquatic vegetation (Birrenkott et al.,
2004; Lewis-Weis et al., 2004; Rocke et al., 2005), and bald eagles and other
avian predators contract the disease by consuming affected prey (Fischer et al.,
2003). All AVM-affected reservoirs contain extensive exotic aquatic
macrophytes, but the same or similar macrophytes are also abundantly present in
other nearby aquatic systems where AVM is not observed. Therefore, it has been
hypothesized that the causative agent is something associated with the
macrophytes, rather than the macrophytes themselves (Birrenkott et al., 2004;
Lewis-Weis et al., 2004).
The macrophyte hydrilla (Hydrilla verticillata), that induced AVM in a
laboratory controlled, mallard (Anas platyrhynchos) feeding study (Birrenkott et
al., 2004), was shown to contain large quantities of an epiphytic cyanobacterial
species. Colonies of this species, a previously uncharacterized member of the
order Stigonematales (Williams et al., 2007), covered 50-90% of the leaf surface
of the hydrilla. Surveys of all known AVM reservoirs, and similar reservoirs
where AVM does not occur, revealed a strong positive correlation between the
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presence of this cyanobacterial species and AVM (Wilde et al., 2005).
Researchers have thus postulated that this cyanobacterial species may be
producing a toxin that causes AVM in birds such as eagles and coots.
Cyanobacteria are ubiquitous in fresh, marine, and brackish waters, as
well as terrestrial environments all over the globe. Numerous genera are known
to produce toxins, which can have hepatotoxic, neurotoxic, or dermatotoxic
effects in human and wildlife populations (Codd, 1995). The current list of
known toxins is incomplete, as new and emerging toxins are recognized due to
advances in analytical techniques and an increasing awareness of the potential for
cyanotoxin poisoning events (Codd, 1995; Codd et al., 2001; Cox et al., 2005).
To date investigations on AVM have been limited to feeding studies
utilizing whole tissues or vegetation samples without any quantitative indication
of the presence of the AVM toxin. The aim of the present study was therefore to
develop a method to extract the causative agent of AVM from aquatic vegetation
as the first step towards purification and characterization of the AVM toxin.
Successful isolation of a partially purified toxic extract will provide an invaluable
tool for in vitro and in vivo toxicology studies including investigations
determining the mechanism of action.

Materials and Methods
Vegetation Collection
Hydrilla was collected from J Strom Thurmond Lake (JSTL), South
Carolina, USA, a site of previous and current AVM epizootics (Fischer et al.,
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2002; Fischer et al., 2003; Lewis-Weis et al., 2004). This vegetation contained
abundant quantities of an epiphytic cyanobacterium that has been suggested as a
possible source of the disease agent (Wilde et al., 2005), with leaf surface area
coverage ranging from 51-100%. Control hydrilla was collected from Lake
Marion, South Carolina, USA, a reservoir with no known history of AVM
occurrence. The suspect cyanobacterium was absent in all collections made from
Lake Marion, as confirmed by microscopic analysis of representative leaves.
Samples were collected weekly, for four weeks, from mid-November to
mid-December 2003. Collections were made with a rake, from the surface to a
depth of approximately 1.5 m, and samples were stored and transported in
covered plastic containers (200 L, Rubbermaid, Atlanta, Georgia, USA). Excess
water was drained and samples were stored at -20°C, except as described below
for the mallard vegetation bioassay.

Mallard Bioassay I - Vegetation
To confirm the presence or absence of the AVM causative agent, half of
the vegetation collected was fed ad libitum to farm-reared mallard ducks in the
laboratory. Detailed results of this study are reported in Chapter 1 (Wiley, 2007).
Briefly, six ducks were fed vegetation from JSTL and six ducks fed vegetation
from Lake Marion. Three ducks in each group received fresh vegetation that had
not been frozen, but kept at room temperature. The remaining three ducks
received vegetation that had been frozen at -20°C, and thawed prior to feeding.
All six ducks receiving JSTL vegetation developed white matter lesions consistent
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with AVM, confirming the presence of the AVM agent. No ducks receiving Lake
Marion vegetation developed AVM lesions, confirming the absence of the AVM
agent. This trial also confirmed that freezing does not affect stability of the AVM
causative agent.

Toxin Extraction
The remaining half of the collected vegetation was used for a solvent
extraction procedure. Frozen vegetation was lyophilized (Virtis Company,
Gardener, New York, USA) and blended (Waring Commercial Blender, Waring,
Torrington, Connecticut, USA) at medium speed for 1 min into a coarse powder
in preparation for extraction. Each of the four weekly samples of vegetation was
lyophilized and extracted separately, and dry weight of each sample was recorded
prior to extraction. Dry weights of weekly samples ranged from 418.48 – 1219.88
g, with an average of 837.83 g. Dried, powdered vegetation was loaded evenly
into three to four, 2 L separatory funnels (200-300 g per funnel) and sequentially
extracted with hexanes, acetone and methanol (Fisher Chemical, HPLC grade,
Fisher Scientific, Hampton, New Hampshire, USA). Solvent was added to the
vegetation until saturated (1-1.5 L of solvent per funnel) and the sample was
mechanically extracted by shaking for five, 2 min periods over 1 h. The extract
was then allowed to drain, and the sample was rinsed with a final volume of
solvent (0.5 L). Drained solvents were pooled. This process was then repeated
with the next solvent. The collected extracts were filtered through 70 mm
Whatman qualitative grade filter paper (Whatman, Inc., Florham Park, New
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Jersey, USA) to remove particulates, and solvent was removed by a rotary
evaporator (Buchi Rotavapor, Buchi, Flawil, Switzerland) with a water bath set no
higher than 28°C. When dry, the extracts were re-suspended in the appropriate
volume of solvent to a concentration of 10 g vegetation/ml solvent, based on the
initial dry weight of the vegetation. Ten percent of this volume was archived for
future in vitro experiments, and the remaining 90% was transferred to a glass
storage jar for use in the in vivo mallard extract bioassay. All extracts were stored
at -20°C.

Mallard Bioassay II - Extracts
In order to determine whether any extract(s) contained the AVM causative
agent, they were evaluated by a mallard bioassay. Eighteen adult male mallards
(average body weight: 1017 g) were obtained from Frost Waterfowl Trust
(Georgetown, South Carolina, USA) and housed in separate floor pens by
experimental group at Godley-Snell Research Center, Clemson University. Birds
were weighed upon arrival and randomly assigned to one of six experimental
groups (three birds per group): JSTL hexanes extract, JSTL acetone extract, JSTL
methanol extract, Lake Marion hexanes extract, Lake Marion acetone extract, and
Lake Marion methanol extract. Commercial feed and water were provided ad
libitum, except as described for gavage. Birds were allowed to acclimate for
three days prior to initiation of treatment.
Prior to dosing, extracts were dried under a N2 stream and re-suspended in
non-toxic vehicles. Hexanes extracts were re-suspended in corn oil (MP
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Biomedicals, Irvine, California, USA), acetone extracts were re-suspended in a
50:40:10 (v:v:v) mixture of corn oil: deionized water: propylene glycol (EMD
Chemicals, Gibbstown, New Jersey, USA), and methanol extracts were resuspended in a 90:10 (v:v) mixture of deionized water: propylene glycol. Each
weekly vegetative extract was re-suspended and dosed separately over the course
of 1 week (4 weeks in total), so as to mimic the conditions in the mallard
vegetation bioassay. This was done to avoid a possible dilution of the toxin if
weekly collections had contained differing toxin concentrations. Extracts were
re-suspended in the appropriate volume of vehicle to deliver the entire extract in
three equivalent doses over one week. Week one extracts were re-suspended in
45 ml of vehicle, to provide a 5 ml dose volume per duck/per dosing. Dose
volume was reduced to 4 ml following the first week in an attempt to reduce
regurgitation that occurred with some birds, as explained in the results section.
Therefore, the remaining extracts were re-suspended in 36 ml, to provide a 4 ml
dose volume per bird/per dosing.
Mallards were orally gavaged with the re-suspended extracts three times a
week for four weeks. Administration of the extracts was immediately followed
by a rinse of the respective vehicle to help wash residual extract out of the feeding
tube. Initial rinse volumes were 3 ml, but were reduced to 2 ml following the first
week of dosing due to the observed regurgitation. Therefore, total dose volume
including extract and rinse was 8 ml during the first week and 6 ml for the
remainder of the study. Food was removed approximately 4 h prior to treatment
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and provided immediately post-treatment. Birds were observed for at least 30
min post-treatment and any regurgitation was noted.
All birds were observed twice daily during the duration of the study and
weights were recorded twice weekly. Birds were euthanized three days following
the final dose administration, 28 d after the treatment was initiated. Birds were
sacrificed by CO2 asphyxiation with a Euthanex CO2/O2 blending system
(Euthanex E-23000, Euthanex Corporation, Palmer, Pennsylvania, USA), using a
70:30 CO2:O2 mixture until birds lost consciousness, followed by 100% CO2 to
complete euthanasia. Whole brains were removed and placed in 10% neutral
buffered formalin in preparation for AVM diagnosis. Whole blood and other
tissues, including liver, kidney, pectoral muscle, gizzard, intestines, and adipose
tissue were also collected and archived at -20°C. Brain analysis was conducted at
the Southeastern Cooperative Wildlife Disease Study by methods previously
described (Fischer et al., 2003).

Results
No clinical signs of neurological disease, including ataxia, incoordination,
or lethargy, were observed during the trial. All animals maintained a fairly
constant body weight throughout the study. On day 15 of the treatment period, a
bird in the AVM-positive methanol group broke a wing during removal from the
pen for treatment. This bird was immediately euthanized and necropsied.
Following gavage, several birds were observed regurgitating the
administered dose, usually within five minutes of administration. This occurred
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in the JSTL and Lake Marion methanol groups following the first two treatments,
with at least one bird in both groups regurgitating. Since the birds were housed in
groups, we were unable to determine with confidence how many birds
regurgitated or which bird regurgitated unless it was observed directly. In an
attempt to prevent regurgitation, the total dose volume was reduced to 6 mL, as
previously described. Following the next two dose administrations, at least one
bird in both methanol groups again regurgitated. However, for all successive
treatments, no regurgitation was observed in the Lake Marion methanol group. At
least one bird, and often all birds, in the JSTL methanol group continued to
regurgitate after each treatment. In addition, at least one bird in the JSTL acetone
group regurgitated three times during the study, and at least one bird in the JSTL
hexane and Lake Marion acetone groups regurgitated once.

The occurrences of

regurgitation by experimental group are shown in Table 3. There was a
significant difference in the occurrence of regurgitation between the JSTL
methanol group and all other groups (p<0.001, Fisher’s exact test).
The results of the brain analysis are shown in Table 4. All three birds in
the JSTL methanol group developed definitive lesions of moderate severity
consistent with AVM (Figure 1). One bird in the JSTL acetone group developed
possible mild lesions (Figure 2). All other birds had no apparent lesions (Figure
1). Brain slides are archived at the Marine Resources Research Institute, South
Carolina Department of Natural Resources, Charleston, South Carolina, USA.
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Table 3. Occurrence of regurgitation in mallards after administration of an extract
of Hydrilla verticillata and associated epiphytes collected from Lake Marion,
South Carolina or J. Strom Thurmond Lake, South Carolina.
Lake Marion

J. Strom Thurmond Lake

Extract

Doses
n

Doses Regurgitateda
n

Doses
n

Doses Regurgitateda
n

Hexanes
Acetone
Methanol

12
12
12

0
1
4

12
12
12

1
3
12

a

Indicates the number of times at least one bird in group regurgitated.

Table 4. Presence of AVM-type brain lesions in mallards after administration of
an extract of Hydrilla verticillata and associated epiphytes collected from Lake
Marion, South Carolina or J. Strom Thurmond Lake, South Carolina.
Lake Marion
n

Birds with
lesions

n

Birds with
lesions

3
3
3

0
0
0

3
3
3

0
1a
3

Extract
Hexanes
Acetone
Methanol
a

J. Strom Thurmond Lake

Possible mild lesions. Results inconclusive.
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250 m

A

250 m

B

Figure 1. Light micrograph images of brain sections of mallards given J. Strom
Thurmond Lake methanol extract (A, B, C) or Lake Marion methanol extract (D).
A, B, and C have definitive lesions of moderate severity in the white matter tracts
(arrows) and were diagnosed as having AVM. Brain D has no observable lesions
and was diagnosed as not having AVM.
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250 m

C

250 m

D

Figure 1. Light micrograph images of brain sections of mallards given J. Strom
Thurmond Lake methanol extract (A, B, C) or Lake Marion methanol extract (D).
A, B, and C have definitive lesions of moderate severity in the white matter tracts
(arrows) and were diagnosed as having AVM. Brain D has no observable lesions
and was diagnosed as not having AVM (Continued).
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250 m

Figure 2. Light micrograph image of the optic lobe of a mallard gavaged with J.
Strom Thurmond Lake acetone extract. Mild lesions are visible in the outer layer
of white matter (arrow) but were not definitive. Therefore a diagnosis of AVM
was not made.

Discussion
This study describes the successful extraction of the putative AVM toxin
from hydrilla and its associated epiphytic cyanobacterial flora. Results of
previous studies have ruled out many other hypothesized toxicants, including
bacterial and viral agents, and the disease was not found to be contagious
(Thomas et al., 1998; Larsen et al., 2003). The pathology of AVM was consistent
with acute toxicosis, with lesions similar to those caused by known toxicants and
no observed immune response (Thomas et al., 1998).
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The toxin appears to be efficiently extracted with methanol, suggesting a
polar compound. One bird administered the acetone extract had possible mild
lesions, though the results were inconclusive. If this bird did indeed have AVM, it
would not be surprising that toxin was also present in the acetone extract, as the
polarity of acetone and methanol do not differ greatly (Snyder, 1978; Marcus,
1998; Fitzpatrick and Dean, 2002). Both solvents also have similar octanol/water
partition coefficients (Kow acetone = -0.24; methanol = -0.70) (Marcus, 1998).
Methanol, however, has a much greater hydrogen bonding ability than acetone
(Marcus, 1998; Fitzpatrick and Dean, 2002), another factor which can play a role
in extraction efficiency. It is also important to remember the matrix effects that
could be involved in the extraction process. While hexanes or acetone could have
similar properties to the toxin, methanol may have been required to release the
toxin from interactions within the matrix. Therefore, while it appears the toxin is
polar, further fractionation of the crude extract will be necessary to provide a
more accurate and detailed description of its physical properties.
The AVM toxin appears to be stable, surviving at -20°C for at least one
year and at room temperature for at least several days. The highest temperature to
which the extracts were exposed was 28°C. It is not known whether or not the
toxin would be stable at higher temperatures. In addition, the toxin does not
appear to be volatile, as it survived extensive lyophilization and vacuum
concentration. However, since the toxin is not known there is no method
available to quantify its concentration and we cannot gauge the efficiency of the
extraction procedure or rates of degradation or loss.
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No typical clinical signs of disease were observed in the AVM-positive
mallards; however, previous field and laboratory data have shown that many
pathologically affected birds do not display signs of disease (Rocke et al., 2002;
Fischer et al., 2003; Birrenkott et al., 2004; Lewis-Weis et al., 2004; Rocke et al.,
2005). It is not yet known why some birds develop clinical signs whereas others
do not. The occurrence and severity of clinical signs has not been positively
correlated to the severity of brain lesions. Toxin concentration, exposure time,
route of administration, and individual susceptibility or health status of the bird
may play a role. Birds with severe lesions can appear clinically normal while
birds displaying signs of neurological impairment may have mild or moderate
lesions (Rocke et al., 2002; Fischer et al., 2003). It is possible that the lesions are
unrelated to clinical signs, and that a second, unidentified pathology exists.
The results of this study suggest that the extracted AVM toxin elicits an
emetic response. Birds in the AVM methanol group that developed lesions
consistently regurgitated following dose administration. While birds in several
other dose groups, including controls, also regurgitated during the study, they did
not do so consistently. Regurgitation as a method of rejection has not been noted
previously in other AVM research; however, this is the first study to administer
the putative toxin in a concentrated form. Previous studies that have been
successful at reproducing AVM in the laboratory have used either AVM
contaminated vegetation (i.e., Hydrilla verticillata) or AVM positive coot tissues
administered ad libitum (Fischer et al., 2003; Birrenkott et al., 2004; Lewis-Weis
et al., 2004; Rocke et al., 2005). Nonetheless, mallards are prone to a
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regurgitation response during toxicity testing which may be caused by the test
substance itself, the volume administered, the vehicle or dosing technique, or a
combination of these factors (OECD, 2002). The mid-experiment reduction in
dosing volume may have helped prevent regurgitation in the Lake Marion
methanol group, but it had no effect on the frequency of regurgitation for the
JSTL methanol birds. Many known toxins and toxicants are known to have an
emetic effect, and it is possible that the AVM toxin is responsible for the
increased frequency of regurgitation observed in the affected birds.
The time of disease onset for the affected birds is not known. At least one
bird developed lesions within two weeks of treatment initiation, as the mallard
euthanized due to a broken wing at day 15 of the treatment period was diagnosed
with AVM. Previous studies have shown that clinical signs and lesions can
develop as early as five days post-exposure to the causative agent (Rocke et al.,
2002; Wiley, 2007, Chapter 1). It is not known whether or not disease onset
occurs with a single acute exposure of a threshold concentration or can develop
after chronic exposure to lower concentrations.
The results of the current study provide further evidence that the
etiological agent of AVM is associated with aquatic vegetation such as hydrilla
and is most likely not the vegetation itself, but rather something associated with
the vegetation, given that the birds receiving Lake Marion control hydrilla
extracts did not develop AVM lesions. Our working hypothesis is that AVM is
caused by an algal or cyanobacterial toxin. The seasonal nature of AVM
epornitics supports this hypothesis, as algal and cyanobacterial blooms are
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successional with seasonal changes. Wilde et al. (2005) conducted algal surveys
at all known sites of AVM epornitics, as well as additional control reservoirs, to
look for algal or cyanobacterial species that were unique to AVM sites or of
unusual abundance during the AVM season. A previously uncharacterized
cyanobacterium of the order Stigonematales emerged as the prime suspect. This
epiphytic cyanobacterium was associated with lake vegetation, particularly
hydrilla, was observed consistently at all known AVM sites, and was the
dominant epiphyte present at most AVM sites during the late fall to early winter,
when AVM is commonly observed (Wilde et al., 2005). At sites where AVM
birds are diagnosed most consistently, the Stigonematalan species covered up to
95% of the leaf surface area of the vegetation during these months. In addition, at
control sites where AVM diagnosed birds are noticeably absent, the
Stigonematales cyanobacterium was not dominant (<10% of the leaf surface area)
and only infrequently observed.
The vegetation used in the present study was selected based on the recent
AVM histories of each study site in addition to the presence or absence of the
Stigonematalan species. JSTL hydrilla producing AVM was extensively covered
by the Stigonematalan species, with 50-100% of the leaf surface area covered
with colonies. In contrast, Lake Marion hydrilla, while containing numerous algal
and cyanobacterial epiphytes, contained no Stigonematalan colonies, based on
microscopic evaluation as well as genetic analysis using real-time PCR (Wiley,
2007, Chapter 1). While the most obvious differences in the JSTL and Lake
Marion vegetation is the presence or absence of the Stigonematalan species, there
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could be other unknown factors involved in disease onset. To confirm the link
between the Stigonematalan cyanobacteria and AVM, the disease must be
demonstrated from direct exposure of birds to pure cultures of the cyanobacteria
species.
Many questions remain to be answered regarding AVM. In addition to
determining the source of disease, research is needed concerning the pathology,
range of susceptible species, and potential management strategies. Mechanism of
action, exposure times and concentrations necessary to produce the disease, acute
versus chronic exposure effects, and possible recovery and/or antidote strategies
are all unknown. Although species susceptibility is currently confined to birds,
the list of susceptible species continues to grow, where in particular, research
focused on mammalian susceptibility is greatly needed. To date, no mammals
have been positively diagnosed with AVM in the wild; however, there has been
anecdotal evidence of possible clinical signs in a beaver (Castor canadensis)
(Lewis-Weis et al., 2004). Several subsequent laboratory studies have
investigated mammalian susceptibility in mice and swine, yet none of these
animals developed lesions (Lewis-Weis et al., 2004; Rocke et al., 2005). The
authors note, however, that the quantities consumed or duration of exposure may
not have been adequate to induce disease.
The successful extraction of the toxin responsible for AVM will assist in
answering many of the questions remaining about AVM, its etiologic agent, and
its mode of action. In addition to being the first step toward isolating and
characterizing the toxin, this successful extraction protocol for separation of the
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AVM toxin from an environmental matrix (i.e., hydrilla – cyanobacterial
complex) will result in numerous opportunities for further research. Researchers
are currently limited to nonspecific, whole animal studies, for which large
quantities of vegetation or tissue samples are required. The production of a toxic
extract through an efficient solvent extraction protocol will improve the utility of
in vivo studies and allow for testing of additional animal models such as mice that
may not readily consume vegetation. In addition, the ability to extract the
putative toxin will allow for in vitro testing. In vitro studies using cell and tissue
cultures would provide essential data on the pathology and mechanism of action.
Identification of an appropriate in vitro model will also provide a more rapid and
sensitive toxin detection method than whole animal bioassays, which will be an
essential tool for bioassay-guided fractionation for toxin purification and chemical
characterization.
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CHAPTER 3
IN VITRO TOXICITY ASSOCIATED WITH THE ETIOLOGIC AGENT OF
AVIAN VACUOLAR MYELINOPATHY

Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting
bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana), and
other avian species in the southeastern U.S. Since the first recorded AVM
epizootic in 1994, over 100 bald eagles have died from the disease, and thousands
of coots have been affected. The cause of AVM has yet to be determined,
although it is associated with consumption of aquatic vegetation – or animals that
have consumed aquatic vegetation – (Birrenkott et al., 2004; Lewis-Weis et al.,
2004; Rocke et al., 2005) and has been linked to a novel cyanobacterial species in
the order Stigonematales that grows on the vegetation (Wilde et al., 2005). The
etiologic agent of AVM is thought to be a toxin, and it has been hypothesized that
the epiphytic cyanobacterium is the source of that toxin.
AVM is characterized by a separation of the layers of the myelin sheaths
in the central nervous system, a condition known as intramyelinic edema (Thomas
et al., 1998). The brain tissue of AVM affected birds has a spongy appearance
under light microscopy due to the vacuoles formed from the separated layers.
Several compounds are known to cause this type of lesion, including triethyltin,

hexachlorophene, bromethalin, and others, but none of these compounds have
been implicated in AVM.
The only current means of detecting and studying the AVM toxin is by in
vivo animal studies. These studies have utilized several avian and mammalian
species as animal models, typically last one to six weeks, and involve the
administration of large quantities of vegetation, tissues, or other test materials. It
is through these studies that researchers have been able to locate the source of
exposure to the AVM toxin (aquatic vegetation and associated epiphytes), have
demonstrated the conveyance of toxicity from prey items to predators (Fischer et
al., 2003), and have explored mammalian susceptibility (Lewis-Weis et al., 2004).
Despite the utility of in vivo studies they have numerous disadvantages.
The trials are labor intensive, generally require large quantities of test material,
and take extensive time to plan and conduct. The endpoint of these studies – the
determination of AVM characteristic lesions in the brain – also takes time to
analyze. The purpose of this study was therefore to develop an in vitro, cell
based bioassay for AVM toxin detection that could be used as an alternative to the
large scale in vivo assays. In addition to reducing the need for animal subjects, an
in vitro assay would allow for small-scale testing, using minimal amounts of the
test solution/substance. The high throughput design and rapid analysis time of
many of these assays allows for testing large numbers of experimental groups and
replicates quickly and can therefore be used as an efficient guide to track toxicity
in toxin fractionation experiments. In vitro assays also represent a simplified

56

system in which cellular mechanisms and damage may be more easily explored
and detected to study toxin mechanisms of action.
We have been successful at extracting the causative agent of AVM from
vegetative samples (Wiley, 2007, Chapter 2). Crude extracts were produced from
vegetation collected at both AVM-positive and AVM-negative sites and examined
for toxicity by a mallard (Anas platyrhynchos) bioassay, which subsequently
identified the crude methanol extract as containing the active toxin. The ability to
produce these extracts has now allowed for the possibility of studying the AVM
toxin in vitro. The purpose of this study was to examine the in vitro toxicity of
these crude methanol extracts in an attempt to discover an endpoint that could be
used in identifying AVM toxin presence in a sample. Since the extracts were in a
crude form, containing a large mixture of potentially bioactive compounds
associated with the vegetation and the associated epiphytic communities,
vegetative extracts from AVM-negative sites served as controls in all
experiments.
Established cell lines served as the experimental model in all assays.
Established, or immortal, cell lines are those that can replicate indefinitely in
culture, being either derived from tumors or transformed to allow for indefinite
division. They have several advantages over primary cultures, which are derived
from animal tissues directly prior to testing and have a finite number of divisions.
Established cultures are easily obtained from cell culture collections and easily
maintained in the laboratory. These cell lines have yielded documented results
and their strengths and weaknesses are well known. They allow for high
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reproducibility between experiments and laboratories and are therefore a good
system to use for in vitro assay development.

Materials and Methods
Cell Culture
To investigate the in vitro toxicity of the crude extracts, initial experiments
examined the cytotoxic potential of the extracts to four established cell lines.
Three mammalian cells lines were tested: two neuronal lines, PC-12 and Neuro-2a
(N2a), and one glial line, C6. These cells are utilized routinely in the research
community and a large body of literature exists on all. A quail neuroretinal cell
line (QNR/D) was also included in the experiments as it was the only avian
neuronal line available as an established culture. In addition to the cytotoxicity
tests, extracts were further tested on C6 cells for the ability to induce apoptosis,
cytoskeletal changes, and cell cycle disruption.
C6, PC-12, Neuro-2a (N2a) and QNR/D cells were obtained from the
American Type Culture Collection (ATCC). C6 and PC-12 cells were maintained
at 37°C with 5% CO2 in Kaighn’s modification of Ham’s F12 medium with 2mM
L-glutamine modified to contain 1.5 g/L sodium bicarbonate and supplemented
with 15% horse serum and 2.5% fetal bovine serum. N2a cells were maintained
at 37°C with 5% CO2 in RPMI medium supplemented with 10% fetal bovine
serum and 1.0 mM sodium pyruvate. QNR/D cells were maintained at 39°C with
5% CO2 in Dulbecco’s Modified Eagle’s medium modified to contain 4.5 g/L
glucose and 1.5 g/L sodium bicarbonate, supplemented with 10% fetal bovine
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serum. C6 and N2a cells were routinely passaged twice weekly and QNR/D and
PC-12 cells were passaged weekly. Cells in passages 5-30 were used in assays.
All cells were grown in the absence of antibiotics.

Vegetation Extractions
All extracts were produced using methods developed in Chapter 2 (Wiley,
2007). Locations and dates of vegetation collections are shown in Table 5.
AVM-positive extracts are defined as those collected at sites with a known history
of AVM. The Stigonematalan cyanobacterium that has been linked to AVM was
also present in these samples, as confirmed by microscopic examination
(Williams, unpubl. data). AVM-negative extracts are defined as those collected
from sites with no known history of AVM. Samples collected at these sites did
not contain the Stigonematalan cyanobacteria, as confirmed by microscopic
examination and PCR (Williams, unpubl. data). Frozen vegetation was
lyophilized (Virtis Company, Gardener, New York, USA) and blended (Waring
Commercial Blender, Waring, Torrington, Connecticut, USA) into a coarse
powder in preparation for extraction and dry weight was recorded. Dried,
powdered vegetation was then sequentially extracted with hexanes, acetone and
methanol (Fisher Chemical, HPLC grade, Fisher Scientific, Hampton, New
Hampshire, USA), filtered, and reduced by vacuum concentration. When dry, the
extracts were re-suspended in the appropriate volume of solvent to a
concentration of 10 g vegetation/ml solvent, based on the initial dry weight of the
vegetation. Prior to cell testing, extracts were sterile filtered through 0.2 Vm
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Table 5. Date of collection and location for vegetation extracted for use in the in vitro experiments. “AVM-negative” refers to those
sites which have no previous history of AVM. “AVM-positive” sites are those that have had documented AVM epizootics.
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Sample ID

Collection Site

Collection Date

AVM-negative
Potato Creek-Aa
Potato Creek-B a
Dens Swamp
SCWMA
Lake Istokpoga

Potato Creek Embayment, Lake Marion, South Carolina
Potato Creek Embayment, Lake Marion, South Carolina
Dens Swamp Cove, Lake Marion, South Carolina
Santee Cooper Wildlife Management Area, South Carolina
Lake Istokpoga, Florida

14 October 2003
17 November 2003
21 December 2005
6 December 2006
12 December 2006

AVM-positive
Parksville-A ab
Parksville-B ab
Petersburg ab
Woodlakeb
DeGray

Parksville Cove, J. Strom Thurmond Lake, South Carolina
Parksville Cove, J. Strom Thurmond Lake, South Carolina
Petersburg Cove, J. Strom Thurmond Lake, Georgia
Woodlake, North Carolina
DeGray Lake, Arkansas

18 November 2003
25 November 2003
1 December 2005
22 November 2005
27 November 2006

a

Samples validated by mallard bioassay.

b

Samples were collected during documented AVM epizootics.

syringe filters (Waters Corporation, Milford, Massachusetts, USA). All extracts
were stored at -20°C and crude methanol extracts were used in the assays.

Cytotoxicity Assays
MTT. Cytotoxicity was determined by measuring 3-[4,5-dimethylthiazol-2-yl]2,5-diphenyl tetrazolium bromide (MTT) reduction, a measure of metabolic
activity. Live cells (or metabolically active cells) are able to reduce MTT,
normally a yellow color, into purple formazan crystals, which are solubilized and
measured spectrophotometrically to indicate the number of viable cells present in
relation to a control population. C6 cells were plated at 1 x 105/ml, N2a and PC12 at 2 x 105/ml, and QNR/D at 3.5 x 105/ml in 96-well plates at 100 Vl per well
and allowed to attach overnight. Cells were dosed with crude methanol extract
from Parksville-A (AVM-positive) and Potato Creek-B (AVM-negative), at
3.125, 6.25, 12.5, 25, 50, and 100 mg/ml. Control (no addition) and vehicle
control (methanol only) groups were also included. All doses were added in 1 Vl
volumes (1% of total volume in well). Following exposure for 24 h, media was
removed and replaced with new media containing 0.8 mg/ml MTT. Cells were
further incubated 2 h at 37°C (C6, N2a, PC-12) or 3 h at 39°C (QNR/D).
Following incubation, media was removed and 100 Vl DMSO added to solubilize
the MTT crystals. Absorbance was measured on a NOVOStar microplate reader
(BMG Lab Technologies, Offenburg, Germany) at 544 nm. Background
absorbance (from media only) was subtracted from all values. Triplicate wells
from each treatment were averaged and expressed as percent of vehicle control.
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Each extract was tested in 3-4 different culture preparations and average means
from the independent tests were compared using a two-tailed, paired student’s ttest as performed by MS Excel, with a p-value of < 0.05 considered significant.
EC50 values were obtained following variable-slope concentration-response
analysis using log-transformed concentration and normalized response as
performed by GraphPad Prism software (v 5.00, GraphPad Software, Inc., San
Diego, California, USA).

LDH. Cell death was also estimated in C6 cells by measuring the leakage of
lactate dehydrogenase (LDH) into the culture medium as an indicator of plasma
membrane damage. C6 cells were plated at 1 x 105/ml in 96-well plates at 100 Vl
per well and allowed to attach overnight. Prior to dosing, the medium was
replaced with serum-free media, as serum contains LDH which can increase the
background absorbance values in the assay. Cells were dosed with crude methanol
extract from Parksville-A (AVM-positive) and Potato Creek-B (AVM-negative),
at 3.125, 6.25, 12.5, 25, 50, and 100 mg/ml. Control (no addition), vehicle control
(methanol only), and positive control (methanol plus 1% Triton X-100 to lyse
cells) groups were also included. All doses were added in 1 Vl volumes (1% of
total volume in well). Following exposure for 24 h, the supernatant was collected,
centrifuged at 5000 rpm for 10 min to remove cellular debris, and analyzed for the
presence of LDH by the Takara LDH Cytotoxicity Detection Kit (Takara Bio Inc,
Japan). This kit measures LDH activity by measuring the reduction of NAD to
NADH/H by the LDH-catalyzed conversion of lactate to pyruvate. The reduced
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NADH/H is then used in the reduction of the tetrazolium salt INT to formazan by
diaphorase. The reduced formazan product, a red dye, was quantified by
measuring the absorbance on a NOVOStar microplate reader at 485nm.
Background absorbance (media only) was subtracted from all values and percent
cytotoxicity was calculated as [(experimental value – vehicle control)/(positive
control – vehicle control)] x 100. Triplicate wells from each treatment were
averaged. The assay was performed three times with different culture
preparations and average means from the independent tests were compared using
a two-tailed, paired student’s t-test as performed by MS Excel, with a p-value of
< 0.05 considered significant. EC50 values were obtained following variableslope concentration-response analysis using log-transformed concentration and
normalized response as performed by GraphPad Prism software.

Apoptosis Assays
C6 cells were examined for apoptosis by two methods: (1) examining cell
surface expression of phosphatidylserine (PS) and (2) measurement of caspase-3
activity. PS is a phospholipid normally associated with the cytoplasmic side of
the cell membrane which is translocated to the outer leaflet of the membrane
during apoptosis (Vermes et al., 1995). Annexin V is a Ca2+-dependent
phospholipid-binding protein with high affinity for PS, and when labeled with a
fluorophore can be used to identify apoptotic cells by binding to exposed PS on
the outer leaflet. Caspases are a family of proteases that mediate the events
associated with apoptosis. Caspase-3 is an effector caspase that functions in cell
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disassembly (Thornberry and Lazebnik, 1998) and its activity can be measured as
an indicator of apoptotic cell death (Gurtu et al., 1997).
C6 cells were plated at ~5 x 105/ml in 6-well plates at 2 ml per well and
allowed to attach overnight. Cells were exposed to crude methanol extracts from
Potato Creek-A (AVM-negative), Woodlake and Parksville-B (AVM-positive) at
12.5 and 50 mg/ml, as well as a vehicle control (methanol), harvested at 4, 8, and
24h exposure, and washed once in cold phosphate buffered saline (PBS). Ten
percent of the cell suspension was used for the Annexin V assay and the
remaining 90% for the caspase assay. For the Annexin V assay, cells were then
stained with fluorescein isothiocyanate (FITC)-labeled Annexin V and propidium
iodide (PI) using the Vybrant Apoptosis Assay Kit #3 (Invitrogen, Carslbad,
California, USA). Briefly, cells were washed once in cold PBS, re-suspended in
annexin-binding buffer (10 mM HEPES, 140 mM NaCl2, 2.5 mM CaCl2, pH 7.4)
to ~1 x 106 cells/ml, and stained with 5Vl of FITC annexin V and 1 Vg/ml of PI at
room temperature for 15 minutes. Cells were analyzed on a Coulter EPICS XL
flow cytometer immediately following incubation with excitation at 488 nm and
emission wavelengths of 525 nm and 635 nm for FITC and PI, respectively. Cells
showing only background fluorescence were determined to be live cells, FITC
positive and PI negative cells were early apoptotic, and cells positive for both
FITC and PI were late apoptotic or dead. Three independent experiments were
conducted and the percentages of dead (PI+) and apoptotic (FITC+/PI-) cells were
compared by a repeated-measures one-way ANOVA followed by Tukey’s
multiple comparison test as performed by GraphPad Prism software. Due to
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insufficient extract quantity only two replicates could be produced with the
Parksville-A 50 mg/ml dose and it was not included in the statistical analysis.
To determine caspase activity, the cells were diluted in PBS to equivalent
cell densities for all samples, centrifuged, and pellets stored at -80°C until
analysis. Caspase activity was analyzed using the EnzChek Caspase-3 Assay Kit
#1 (Invitrogen). The principle of this kit is the caspase activated cleavage of the
7-amino-4-methylcoumain-derived substrate Z-DEVD-AMC. Upon cleavage,
this substrate yields a blue fluorescent product that can be measured as an
indicator of caspase activity in the sample. Briefly, each pellet was re-suspended
in cell lysis buffer and subjected to one freeze-thaw cycle to lyse cells. Following
centrifugation, 50 Vl of supernatant was transferred to individual wells of a 96well plate. 50 Vl of lysis buffer was used as a background control. 50 Vl of
substrate solution (0.2 mM Z-DEVD-AMC substrate; 10 mM dithiothreitol; 20
mM PIPES; 4 mM EDTA; 0.2% CHAPS) was added to each sample and control
well and incubated 30 min at room temperature in the dark. Fluorescence was
measured using a NOVOStar plate reader with excitation at 360 ±10 and emission
detection at 450±10 nm. Background fluorescence (lysis buffer control wells)
was subtracted from each experimental value. Three independent experiments
were conducted and average fluorescence was compared among treatments by a
repeated-measures one-way ANOVA followed by Tukey’s multiple comparison
test as performed by GraphPad Prism software.
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Cytoskeletal Staining and Morphological Observations
F-actin. C6 cells were plated on poly-l-lysine coated coverslips at 1 x 105
cells/ml and allowed to attach overnight. Cells were dosed with Potato Creek-A
(AVM-negative) and Woodlake (AVM-positive) crude methanol extracts at 12.5
mg/ml, as well as vehicle control (methanol only). Following exposure at 0, 1, 2,
4, 8, and 24 h, coverslips were washed twice in PBS, fixed in 3.7% formaldehyde
for 10 min at room temperature, and permeabilized with 0.1% Triton X-100 for 3
min at room temperature. After two PBS washes, cells were stained with
phalloidin (Oregon Green® 488 phalloidin, Invitrogen) plus 1% bovine serum
albumin for 20 min. DAPI (4’,6-diamidino-2-phenylindole) (0.25Vg/ml) was
added and incubated 5 min. Slides were washed twice in PBS and mounted on
glass slides with Fluoromount G. Fluorescence, phase contrast, and differential
interference contrast images were taken on an Olympus BX51 microscope with an
Olympus DP70 digital camera (Olympus America, Inc., Central Valley,
Pennsylvania, USA).

Tubulin. C6 cells were plated onto poly-l-lysine coated coverslips at 1 x 105
cells/ml and allowed to attach overnight. Cells were dosed with AVM-negative
(Potato Creek-A, Potato Creek-B) and AVM-positive extracts (Woodlake and
Parksville-A) at 12.5 mg/ml, as well as vehicle control (methanol). Following
exposure for 0, 1, 2, 4, 8, and 24 h coverslips were washed twice in PBS, fixed in
4% paraformaldehyde 5 min at room temperature (RT), washed twice in PBS, and
permeabilized with 100% methanol (-20°C) for 5 min. Coverslips were then
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washed twice in PBS and incubated with 5% normal goat serum (Vector
Laboratories, Inc., Burlingame, California, USA) in PBS for 45 min at 4°C, then
incubated overnight at 4°C with primary antibody (monoclonal mouse anti-\tubulin, Sigma-Aldrich, St. Louis, Missouri, USA) at 1:400 in PBS. The
following day coverslips were washed twice in PBS and incubated 1h at RT with
secondary antibody (anti-mouse IgG-FITC produced in goat, Sigma-Aldrich),
washed twice in PBS, and stained with DAPI at 0.25 Vg/ml for 5 min at RT in the
dark. After a final PBS wash coverslips were mounted onto glass slides with
Fluoromount G. Fluorescence, phase contrast, and differential interference
contrast images were taken on an Olympus BX51 microscope on an Olympus
BX51 microscope with an Olympus DP70 digital camera.

Cell Cycle Analysis by Flow Cytometry
Cell cycle analysis was conducted by measuring the DNA content of cells
stained with propidium iodide. C6 cells were plated at ~5 x 105/ml in 6-well
plates at 2 ml per well and allowed to attach overnight. Cells were exposed to
vehicle control (methanol) and all AVM-negative and AVM-positive extracts
(Table 1). In addition, cells were exposed to triethyltin bromide (97%, Acros
Organics, New Jersey, USA) at 1.0, 5.0, 10.0, 20.0 and 50.0 VM, dissolved in
methanol. Following exposure at 4, 8, and/or 24 h, cells were harvested with
trypsin-EDTA (supernatant was also collected to include any detached cells),
pelleted by centrifugation at 3500 rpm for 5 min, and fixed in ice-cold 70%
ethanol overnight at -20°C. Cells were then pelleted (3500 rpm, 5 min, room
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temperature) and stained with 10 Vg/ml propidium iodide in PBS containing 10
Vg/ml RNase for 1 h at room temperature in the dark. Flow cytometry analysis
for cell cycle distribution was conducted on a Coulter EPICS XL with excitation
at 488 nm and an emission wavelength of 635 nm. A minimum of 10,000 cells
were counted. The percentage of cells in G1, S, and G2/M phases were estimated
using Multicycle software (Phoenix Flow Systems, San Diego, California, USA).
Three independent experiments were conducted and the percentages of cells in
each phase were compared by a repeated-measures one-way ANOVA followed by
Tukey’s multiple comparison test as performed by GraphPad Prism software.

Results
Cytotoxicity Assays
Both Potato Creek-B and Parksville-A extracts reduced MTT conversion
in a concentration-dependent manner for all cell lines (Figure 3), with complete
cell death occurring at the highest concentration (100 mg/ml). Direct comparison
of response to Potato Creek-B and Parksville-A extracts at each concentration
revealed few significant differences (Figure 3). Calculated EC50 values (Table 6)
did not differ significantly between the AVM-positive and AVM-negative
extracts for C6 and PC-12 cells, but EC50’s for Parksville-A were significantly
lower than Potato Creek-B for N2a and QNR/D cells. N2a cells were the most
sensitive cell line tested, with the lowest EC50 values for both extracts. LDH
release in C6 cells was also induced in a concentration-dependent manner, with
cytotoxicity reaching a plateau at approximately 90% at 25 mg/ml (Figure 4).
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Figure 3. Effect of Potato Creek-B (]) and Parksville-A (^) crude methanol
extracts on cytotoxicity of C6, PC-12, N2a, and QNR/D cell lines as determined
by the MTT assay. Data are expressed as a percentage of viable cells relative to
vehicle control (methanol only), with each point representing mean ± SEM of
three or four independent experiments. Asterisks (*) signify a significant
difference (p < 0.05) between the Potato Creek and Parksville extract for that
concentration.
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Figure 3. Effect of Potato Creek-B (]) and Parksville-A (^) crude methanol
extracts on cytotoxicity of C6, PC-12, N2a, and QNR/D cell lines as determined
by the MTT assay. Data are expressed as a percentage of viable cells relative to
vehicle control (methanol only), with each point representing mean ± SEM of
three or four independent experiments. Asterisks (*) signify a significant
difference (p < 0.05) between the Potato Creek and Parksville extract for that
concentration (Continued).
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Table 6. Effective concentrations of crude extract that elicit half-maximal
viability (EC50) for each cell line following exposure for 24 h, as measured by the
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) reduction
assay or the lactate dehydrogenase (LDH) assay.

Cell line

Crude Extract EC50 (mg/ml) (mean ± SE)
Potato Creek-B
(AVM-negative)

Parksville-A
(AVM-positive)

MTT
C6
PC-12
N2a
QNR/D

18.15 ± 1.03
24.55 ± 1.06
4.52 ± 1.08
17.30 ± 1.09

17.59 ± 1.13
25.32 ± 1.08
2.51 ± 1.09*
9.13 ± 1.17*

LDH
C6

11.92 ± 1.12

14.50 ± 1.11

* Significantly different from corresponding Potato Creek-B value, p< 0.05.
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Figure 4. Effect of Potato Creek-B (]) and Parksville-A (^) crude methanol
extracts on cytotoxicity of C6 cells as determined by the LDH assay. Data are
represented as percent cell death, with each point representing mean ± SEM of
three independent experiments. Asterisks (*) signify a significant difference (p <
0.05) between the Potato Creek and Parksville extract for that concentration.

The calculated LDH EC50 values (Table 6) for Parksville-A and Potato Creek-B
were not significantly different.
Cell morphology was also noted at 4 and 24 h after exposure to the
extracts in these experiments. In all cells lines the two high doses of extract
contained large amounts of debris which obscured the cells and prevented any
reliable observations. At the lower doses, a slight loss of cellular processes and
increased rounding was noted in varying degrees with PC-12, N2a, and QNR/D
cells in a concentration-dependent manner. This effect was observed in cells
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exposed to both extracts, with the Parksville-A extract causing slightly greater
changes in morphology but not being markedly different from Potato Creek-B. A
more pronounced rounding effect was seen in C6 cells and was consistently
observed at all concentrations of the Parksville-A extract but not in the Potato
Creek-B extract. Small blebs could be seen on the cell surface of these rounded
cells and it was hypothesized that these cells may be undergoing apoptosis. To
test this hypothesis C6 cells were examined for markers of apoptosis and changes
in cell morphology were also further explored by cytoskeletal staining, as
described below.

Apoptosis Assays
To determine if the cell death observed in the cytotoxicity assays could be
attributed to apoptotic mechanisms, C6 cells were exposed to AVM-positive
(Parksville-A, Woodlake) and AVM-negative (Potato Creek-A) extracts and
examined for markers of apoptosis. Cell surface expression of phosphatidylserine
was measured using FITC-Annexin V, with propidium iodide used to distinguish
cells in late apoptosis or necrosis. The percentage of apoptotic cells (FITC+/PI-)
in populations exposed to AVM-negative and AVM-positive extracts did not
differ significantly from control populations at any time point and consisted of a
very small fraction of the total cell population (<2%). The percentage of dead/late
apoptotic cells (PI+) did not differ from control populations at the low dose of any
extract, nor did it change over time. However, the high dose of Potato Creek-A
and Woodlake extracts induced a significant rise in PI+ cells at 24 h (Figure 5).
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The Annexin V assay is unable to differentiate cells present in late apoptosis or
necrosis, since both populations will stain with PI and FITC. Therefore, while
there is an increase in the number of dead cells in the population with the high
dose of extract, it is not clear by which mechanism these cells died. Since the
percentage of FITC+/PI- cells remained low throughout the experiment and did
not differ between samples it is reasonable to assume that the majority of the dead
cells did not undergo apoptosis.
As a second measure of apoptosis, caspase-3 activity was monitored in C6
cells at 4, 8, and 24 h after exposure to these extracts. Potato Creek-A and
Woodlake extracts both resulted in decreased caspase activity compared to control
populations at 8 and 24 h with the high dose (50 mg/ml) (Figure 6). No other
significant differences were observed. The decrease in caspase activity seen at
the high doses of extracts may be due to increased cell death in these populations,
as was observed in the Annexin assay. Cell death was not preceded by an
increase in caspase activity. Taken together, these data indicate that neither the
AVM-positive nor AVM-negative extracts significantly induce apoptosis in C6
cells at the concentrations and time points examined.
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Figure 5. Dead/late apoptotic C6 cells as indicated by staining with propidium
iodide following exposure to crude methanol extracts at 12.5 and 50 mg/ml for 4,
8, or 24 h. Data represent means ± SEM for 3 independent experiments. Asterisk
(*) indicates significant difference (p < 0.05) from control.
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Figure 6. Caspase-3 activity in C6 cells following exposure to crude methanol
extracts at 12.5 and 50 mg/ml for 4, 8, or 24 h. Data represent means ± SEM for
3 independent experiments. Asterisk (*) indicates significant difference (p < 0.05)
from control.

Cytoskeletal Staining and Morphological Observations
To further investigate the morphological changes noted in the cytotoxicity
assays, C6 cells were exposed to Potato Creek-A and Woodlake extracts as well
as vehicle control for 0, 1, 2, 4, 8, and 24 h, stained for F-actin and \-tubulin and
viewed under fluorescent and light microscopy. Control cells varied in
morphology from flat, polygonal cells with no or varying numbers of processes to
elongated bipolar cells. Phalloidin staining revealed organized microfilament
networks in the majority of cells, consisting of parallel bundles of filaments
(Figure 7). Spiky filopodia were seen protruding from the cell surface of many
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A

B

C

D

Figure 7. Phase contrast and fluorescent images of C6 cells exposed to vehicle
control (methanol) for 4 h and stained to visualize F-actin (green) and DNA
(blue). Organized parallel bundles (A) and spiky filopodia (B) were present.
Rounded, mitotic cells with intense actin staining (C) and condensed
chromosomes (D) were also observed.
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cells (Figure 7). A small number of rounded cells were also present with intense
actin staining, especially at the periphery (Figure 7). Parallel DAPI staining
revealed condensed chromosomes in the nuclei of these rounded cells, indicating
these cells were undergoing mitosis (Figure 7). Control cell morphology did not
change during the 0-8 h time points, but the percentage of elongated, bipolar cells
was greatly increased at 24 h and the cell density was also increased (Figure 8).
Tubulin staining revealed normal, organized microtubule networks in interphase
cells and normal spindle apparatus in mitotic cells (Figure 9).
Cells exposed to Potato Creek-A extract did not appear to differ from
control cells in morphology, microfilament or microtubule organization, or in the
percentage of cells undergoing cell division (Figures 8, 10, 11). However, cells
treated with Woodlake extract experienced an increase in the proportion of
rounded cells beginning as early as 1 h after exposure and continuing through 24
h (Figure 8). DAPI staining revealed condensed chromosomes in the nuclei of
these cells, but unlike control and Potato Creek-B extract treated cells the
chromosomes were consistently observed only in the beginning stages of mitosis
and did not appear to move past prophase (Figures 12, 13). F-actin organization
in interphase cells appeared to be normal (Figure 12), with the exception of the
24 h time point in which few cells remained in the normal morphology and those
that had not yet rounded had less organized parallel bundles. In addition, fewer
processes were seen in cells at the latter time points and there was an increase of
the amorphous actin concentrations at the cell periphery (Figure 12), which may
represent processes retracting as cells began to round. Tubulin staining revealed
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Control

Potato Creek 10-14

Woodlake

1h

2h

4h

8h

24h

Figure 8. Phase contrast images of C6 cells exposed to vehicle control (methanol)
and crude methanol extracts from an AVM-negative (Potato Creek-A) and AVMpositive (Woodlake) site.
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Figure 9. Fluorescent images of C6 cells exposed to vehicle control (methanol)
for 4 h and stained to visualize microtubules (green) and DNA (blue). Normal
mitotic spindles (arrows) and chromosomes (arrowheads) can be seen in various
stages of mitosis.
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Figure 10. Phase contrast and fluorescent images of C6 cells exposed to crude
methanol extract from an AVM-negative site (Potato Creek-A) for 4 h. Cells
were stained to visualize F-actin (green) and DNA (blue). Mitotic cells can be
seen dividing (arrows).
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Figure 11. Fluorescent images of C6 cells exposed to crude methanol extract
from an AVM-negative site (Potato Creek-A) for 4 h and stained to visualize
microtubules (green) and DNA (blue). Normal mitotic spindles (arrows) and
chromosomes (arrowheads) can be seen in various stages of mitosis.
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Figure 12. Phase contrast and fluorescent images of C6 cells exposed to crude
methanol extract from an AVM-positive site (Woodlake) for 4 h. Cells were
stained to visualize F-actin (green) and DNA (blue). Rounded cells (arrows) have
condensed chromosomes and are thought to be present in early mitosis.
Amorphous accumulations of actin (arrowhead) at the cell periphery may
represent processes retracting as cells round.
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Figure 13. Fluorescent images of C6 cells exposed to crude methanol extract from
an AVM-positive site (Woodlake) for 4 h and stained to visualize microtubules
(green) and DNA (blue). Cells are uniformly present in prophase or
prometaphase as condensed chromosomes can be seen (arrowheads), but there is
no corresponding mitotic spindle formation (arrows).
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normal microtubule networks in interphase cells but the normal spindle apparatus
was absent or poorly defined in the majority of mitotic cells (Figure 13). Normal
spindle asters could be seen in some cells at the earlier time points (1 and 2 h post
exposure), but at 4, 8, and 24h the majority of mitotic cells contained no visible
spindle apparatus and no clear organization of microtubules (Figure 13). Taken
together, the cytoskeletal stains suggest the Woodlake extract slows or blocks
progression from prophase to metaphase. An additional AVM-positive
(Parksville-A) and AVM-negative (Potato Creek-B) extract were subsequently
tested on C6 cells and stained for tubulin at 4, 8, and 24 h. Cells exposed to
Potato Creek-B did not differ from control cells. Parksville-A induced a similar
effect to Woodlake, with an increase in rounded, mitotic cells and an absence of
spindle microtubules.

Cell Cycle Analysis
To further investigate the potential mitotic block revealed with the
cytoskeletal staining, a cell cycle analysis was conducted on several extracts from
both AVM-positive and AVM-negative sites. C6 cells were exposed to the
extracts at 12.5 and 50 mg/ml for 4, 8, and 24 h and the percentage of cells in G1,
S, and G2/M was determined by flow cytometry. Percentages of cells in each
phase are displayed in Table 7 (AVM-negative) and Table 8 (AVM-positive) and
representative histograms are shown in Figures 14 and 15. AVM-positive extracts
consistently produced an increase in the percentage of cells in S-phase or G2/M
phase compared to control populations, and a corresponding decrease of cells in
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G1. The high dose (50 mg/ml) generally resulted in an increase in S-phase cells,
while the low dose (12.5 mg/ml) produced an increase of cells in G2/M. This
increase could be seen as early as 4 h, and with the high dose did not change at
the 8 or 24 h time points. At the low dose, depending on the extract, the
percentage of cells in G2/M that were initially increased at 4 h either continued to
increase at 8 and 24 h (DeGray, Parksville-A) or decreased and returned to near
control levels by 24 h (Woodlake, Parksville-B).

The presence of a broad sub-

G1 peak, most likely representing cellular fragments and debris in the high doses
of extract, indicates an increase in cell death at these concentrations.
Cells exposed to extracts from AVM-negative sites at the low dose were
not significantly different than control cell populations at any time point. The high
dose of Potato Creek-A and Potato Creek-B produced a slight but not significant
increase in the proportion of S-phase and G2/M cells at all time points. The high
dose of SCWMA extract cause a significant increase in the proportion of cells in
G2/M phase at 4 and 8 h, but populations returned to near control levels by 24 h.
Because the cell cycle analysis revealed differences in the extracts of the
AVM-negative and AVM-positive sites tested, additional extracts from one
AVM-positive site and two AVM-negative sites were prepared and analyzed by
this assay to determine if the results would remain consistent. For these analyses
cells were exposed to the extracts for four hours only, since this time point was
adequate in detecting the cell cycle disruption in the initial tests and the effect was
often lost at the later time points. Results are shown in Table 9 and Figure 16.
The AVM-positive extract (Petersburg) induced a significant increase of G2/M
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Table 7. Cell cycle distribution of C6 cells exposed to AVM-negative extracts from Potato Creek Embayment, South Carolina and the
Santee Cooper Wildlife Management Area (SCWMA), South Carolina and vehicle control (methanol) for 4, 8, or 24 h.

4h

8h

24 h
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G1

S

G2/M

G1

S

G2/M

G1

S

Control

47.30 ± 4.88

31.97 ± 3.10

20.73 ± 1.77

59.33 ± 2.87

28.97 ± 3.09

11.70 ± 0.96

75.23 ± 2.76

18.10 ± 1.25

6.67 ± 1.56

Potato Creek
A
12.5 mg/ml
50.0 mg/ml

46.73 ± 5.40
42.10 ± 7.16

32.27 ± 3.32
36.17 ± 6.13

21.03 ± 2.27
21.73 ± 1.58

58.73 ± 2.63
53.37 ± 4.81

29.30 ± 4.06
26.27 ± 2.81

12.00 ± 1.60
20.37 ± 2.34

69.83 ± 4.09
64.43 ± 4.17

21.17 ± 2.04
22.83 ± 6.61

9.03 ± 2.07
12.73 ± 2.70

Potato Creek
B
12.5 mg/ml
50.0 mg/ml

50.83 ± 8.29
43.67 ± 5.97

30.87 ± 5.55
34.33 ± 5.06

18.30 ± 2.99
22.00 ± 0.96

57.80 ± 2.43
54.60 ± 4.37

29.70 ± 3.75
25.90 ± 2.00

12.47 ± 1.71
19.50 ± 3.02

67.70 ± 6.33
63.27 ± 6.89

21.37 ± 2.65
22.77 ± 2.88

10.90 ± 3.75
13.97 ± 4.02

SCWMA
12.5 mg/ml
50.0 mg/ml

47.40 ± 5.28
31.70 ± 5.01*

32.47 ± 3.52
34.10 ± 6.24

20.13 ± 2.03
34.17 ± 2.29*

62.07 ± 2.23
36.10 ± 8.30*

27.27 ± 3.29
28.77 ± 4.34

10.70 ± 1.47
35.13 ± 6.91*

75.23 ± 1.74
67.30 ± 2.07

17.97 ± 0.62
13.80 ± 1.80

6.80 ± 1.12
18.90 ± 2.69

*

Significantly different from control value, p < 0.05.

G2/M

Table 8. Cell cycle distribution of C6 cells exposed to AVM-positive extracts from Parksville Cove (J. Strom Thurmond Lake), South
Carolina; Woodlake, North Carolina; DeGray Lake, Arkansas; and vehicle control (methanol) for 4, 8, or 24 h.

4h

8h

24h
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G1

S

G2/M

G1

S

G2/M

G1

S

Control

47.30 ± 4.88

31.97 ± 3.10

20.73 ± 1.77

59.33 ± 2.87

28.97 ± 3.09

11.70 ± 0.96

75.23 ± 2.76

18.10 ± 1.25

6.67 ± 1.56

Parksville-B
12.5 mg/ml
50.0 mg/ml

33.07 ± 4.81*
29.57 ± 2.98*

31.47 ± 3.00
49.83 ± 5.23*

35.47 ± 1.94*
20.63 ± 3.27

45.50 ± 3.94
28.67 ± 2.62*

29.87 ± 2.71
50.13 ± 4.51

24.67 ± 2.74
21.23 ± 2.28

64.00 ± 3.79
27.57 ± 2.23*

21.27 ± 2.02
48.17 ± 5.78*

14.73 ± 2.19
24.27 ± 3.63*

Woodlake
12.5 mg/ml
50.0 mg/ml

27.83 ± 4.67*
26.90 ± 2.17*

34.43 ± 3.16
49.43 ± 3.96*

37.73 ± 1.75*
23.67 ± 1.78

38.00 ± 8.35*
26.53 ± 1.83*

34.47 ± 8.29
49.43 ± 5.48

27.53 ± 4.53*
24.10 ± 3.86

59.23 ± 2.34
26.20 ± 0.92*

20.77 ± 1.00
45.63 ± 5.15*

20.03 ± 1.56
28.20 ± 4.28*

DeGray
12.5 mg/ml
50.0 mg/ml

19.67 ± 1.43*
25.27 ± 1.07*

36.80 ± 3.78
42.07 ± 1.85*

43.57 ± 2.92*
32.67 ± 0.98*

10.20 ± 0.30*
15.97 ± 2.18*

29.87 ± 2.37
48.67 ± 5.36

59.93 ± 2.02*
35.37 ± 4.62*

10.03 ± 0.33*
20.33 ± 2.95*

15.27 ± 1.16
34.53 ± 8.63

74.73 ± 0.88*
45.13 ± 7.11*

Parksville-A
12.5 mg/ml

20.00a

26.20

53.80

15.30

23.90

60.90

32.60

18.80

48.60

a

*

Values represent only one replicate and are therefore not included in statistical analysis.
Significantly different from control value, p < 0.05.
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Figure 14. Representative histograms of cell cycle distribution in C6 cells treated
with crude hydrilla extracts from AVM-negative sites and analyzed 4, 8 and 24 h
after exposure. Total DNA content is measured as the intensity of propidium
iodide fluorescence. The experiment was repeated three times with similar
results.
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Figure 15. Representative histograms of cell cycle distribution in C6 cells treated
with crude hydrilla extracts from AVM-positive sites and analyzed 4, 8 and 24 h
after exposure. Total DNA content is measured as the intensity of propidium
iodide fluorescence. The experiment was repeated three times with similar
results.

90

Table 9. Cell cycle distribution of C6 cells exposed to AVM-positive (Petersburg
Cove, South Carolina) and AVM-negative (Dens Swamp, South Carolina; Lake
Istokpoga, Florida) extracts and a vehicle control (methanol) for 4h.

G1

S

G2/M

Control

58.33 ± 2.97

30.77 ± 2.59

10.87 ± 1.22

Petersburg
12.5 mg/ml
50.0 mg/ml

36.80 ± 0.10*
54.00 ± 4.51

33.57 ± 2.84
30.53 ± 0.84

29.63 ± 2.94*
15.47 ± 4.05

Dens Swamp
12.5 mg/ml
50.0 mg/ml

60.87 ± 1.37
53.83 ± 1.02

28.20 ± 1.11
31.23 ± 1.19

10.93 ± 1.19
14.90 ± 1.42

Istokpoga
12.5 mg/ml
50.0 mg/ml

59.53 ± 1.43
60.23 ± 0.79

30.23 ± 2.28
28.57 ± 1.77

10.23 ± 1.79
11.20 ± 1.83

*Significantly different from control value, p < 0.05.
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Figure 16. Representative histograms of cell cycle distribution in C6 cells treated
with crude hydrilla extracts and analyzed 4 h after exposure. Total DNA content
is measured as the intensity of propidium iodide fluorescence. The experiment
was repeated three times with similar results.
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phase cells at the low dose and did not differ from control populations at the high
dose. A large sub-G1 peak indicating cell death was also seen at the high dose.
Neither AVM-negative extract induced changes in cell cycle distribution at the
low dose, while one (Dens Swamp) induced a slight but not significant increase in
G2/M cells at the high dose.
In an attempt to determine if similar cell cycle disruption could be seen in
a known compound causing similar effects to AVM in vivo, and to better
understand the dose-response for the cell cycle results, cells were exposed to a
dilution series of triethyltin (TET). Results are seen in Table 10 and Figure 17
and are similar to those observed with the crude extracts. At 1.0 VM, TET did not
differ significantly from control values, although there was a slight increase in
G2/M at 4 h with one replicate. At 5.0 VM, TET caused a significant increase of
cells in G2/M that continued through 24 h. An increase in S-phase and G2/M cells
resulted from 10 VM TET and did not change notably over the time points, similar
to that observed in the high dose of AVM-positive extracts. The highest
concentrations of TET (20, 50 VM) caused a slight but not significant increase in
S and G2/M cells at 4 h, with no subsequent changes at the later time points,
leading to significantly more cells in S-phase than that of controls by 24 h. The
sub-G1 peaks indicating cell death also increased with the higher doses.

93

Table 10. Cell cycle distribution of C6 cells exposed to triethyltin for 4, 8, or 24 h.

4h

8h

24h
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G1

S

G2/M

G1

S

G2/M

G1

S

Control

47.30 ± 4.88

31.97 ± 3.10

20.73 ± 1.77

59.33 ± 2.87

28.97 ± 3.09

11.70 ± 0.96

75.23 ± 2.76

18.10 ± 1.25

6.67 ± 1.56

1.0 VM

52.23 ± 3.23

28.40 ± 1.82

18.37 ± 3.43

68.37 ± 1.64

19.50 ± 0.58

12.10 ± 1.95

80.03 ± 2.30

14.77 ± 0.37

5.20 ± 1.93

5.0 VM

41.07 ± 5.69

35.93 ± 4.11

22.97 ± 3.79

33.93 ± 7.11*

29.37 ± 10.50

36.70 ± 6.31*

28.40 ± 4.92*

28.20 ± 3.43

43.37 ± 4.39*

10.0 VM

35.23 ± 6.69

41.53 ± 10.13

23.27 ± 6.12

32.30 ± 4.59*

39.30 ± 7.90

28.43 ± 4.69

29.07 ± 3.54*

40.27 ± 5.36*

30.63 ± 2.31*

20.0 VM

53.57 ± 2.29

35.83 ± 5.56

10.60 ± 3.41

55.87 ± 2.46

29.00 ± 3.76

18.47 ± 2.74

49.40 ± 1.67*

32.87 ± 2.03*

17.73 ± 3.43

50.0 VM

51.00 ± 2.02

34.60 ± 0.50

14.43 ± 2.10

49.70 ± 1.82

36.00 ± 0.50

14.37 ± 2.25

45.17 ± 2.02*

41.10 ± 0.92*

13.67 ± 1.48

*

Significantly different from control value, p < 0.05.
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Figure 17. Representative histograms of cell cycle distribution in C6 cells treated
triethyltin and analyzed 4, 8, and 24 h after exposure. Total DNA content is
measured as the intensity of propidium iodide fluorescence. The experiment was
repeated three times with similar results.
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Discussion
AVM-positive extracts caused a significant disruption of the cell cycle in
C6 cells. At lower concentrations, the extracts seem to slow progression through
mitosis, causing an increase of cells in G2/M at 4 h. This effect is then either
alleviated after 24 h, presumably at lower concentrations, or cells continue to
accumulate in G2/M. Higher concentrations cause a buildup of cells is S-phase as
well as G2/M at 4 h, with no subsequent changes occurring through 24 h. The
high concentrations of AVM-positive extracts were also associated with an
increase in cell death. TET caused a similar cell cycle arrest. Lower, sub-lethal
concentrations of both TET and AVM-positive extracts caused an increase in
G2/M phase cells while higher concentrations resulting in cell death induce more
of an increase in S-phase cells. The highest concentrations do not appear to
significantly affect the cell cycle, most likely because these concentrations result
in acute cell death (20 and 50 VM TET, 50 mg/ml Petersburg extract). AVMnegative extracts also caused a slight increase in G2/M cells, but were not nearly
as efficient at inducing this effect as AVM-positive extracts, with only one extract
(SCWMA) inducing a significant change in cell cycle distribution at only the high
concentration.
The cell cycle assay appears to be a useful tool in identifying extracts from
AVM-positive sites, although it is unknown whether or not the cell cycle arrest is
caused by the etiologic agent of AVM. An increase in G2/M cells was also noted
in C6 cells exposed to AVM-negative extracts, although the effect was
consistently lower than that produced with AVM-positive extracts and all
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populations were recovered by 24 h. It is possible that some of the AVMnegative extracts tested could have contained the AVM agent in small amounts.
For instance, the SCWMA extract, which induced a significant G2/M arrest at 4 h,
came from a site with no known history of AVM, but the vegetation had not been
previously tested by in vivo bioassay to confirm that the AVM agent was not
present. The two extracts from Potato Creek, which had been previously tested
by mallard bioassay and did not induce AVM lesions, also induced a very slight
increase in G2/M cells. It could be that these samples did contain low levels of
the causative agent and that the cell cycle analysis is a more sensitive measure
than in vivo assays. The Stigonematalan cyanobacteria that is suspected to be the
source of the AVM toxin was not present in the vegetation collected from AVMnegative sites, as confirmed by microscopic analysis and PCR (Williams, unpubl.
data). However, despite the strong correlations between this cyanobacteria and
AVM-positive reservoirs (Wilde et al., 2005) a direct causal relationship between
this cyanobacterium and AVM has not yet been established and it is possible that
this cyanobacterium is not involved. If the etiologic agent of AVM was not
present in the vegetation collected from the AVM-negative sites then the observed
cell cycle arrest could be due to another unrelated compound present in the crude
extract. Another possibility is that the AVM toxin could be having an additive or
synergistic effect with some other compound. Isolation of the AVM toxin from
the crude extract will be necessary to further evaluate these results.
Cell cycle arrest has been noted in at least one compound known to
produce intramyelinic edema –TET. Zucker et al. (1989) found that TET induced
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a cell cycle block in G2/M at or above 5 VM in murine erythroleukemic cells after
4 h of exposure. Similar results were found in this study, with TET inducing
increases in both G2/M and S-phase cells at 5 and 10 VM. In addition, the TET
derivative triethyltin(IV)lupinylsulfide hydrochloride, which was synthesized and
tested as a potential anticancer drug, induced a 42% increase in G2/M cells at 24 h
in HCT-8 human colon carcinoma cells (Barbieri et al., 2001). The mechanism
behind these effects has not been elucidated.
The increase in S-phase cells at higher concentrations of extract appears to
coincide with the increase in cytotoxicity. S-phase is the period of DNA synthesis
and reports of S-phase arrest are less frequent than that of G2/M or G1 arrest in the
literature on cell cycle disruption. S-phase arrest or delay has been reported with
compounds that inhibit DNA replication, such as camptothecin, as well as in cells
that have been subjected to radiation (Paulovich and Hartwell, 1995; Shao et al.,
1997). The authors of these studies suggest the existence of an S-phase
checkpoint that may delay progression through this phase in response to DNA
damage. It is possible that the S-phase arrest seen at the higher doses of AVMpositive extracts may be related to an effect on DNA replication, but further study
will be needed to determine the mechanism involved.
Flow cytometry cannot distinguish between cells in G2 or mitosis, but
DAPI staining revealed an apparent increase of cells with condensed
chromosomes following AVM-positive extract exposure, suggesting that the cells
are arrested in mitosis and not G2. The mechanism behind this arrest is not clear
and will require further study. Cells appear to be arrested in prophase, after
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chromosome condensation but before mitotic spindle assembly. While a normal
spindle assembly was observed in control cells and those treated with AVMnegative extract, spindle microtubules were not observed in the majority of
mitotic cells exposed to AVM-positive extracts. It is not clear whether the
absence of spindle microtubules is due to a disruption of normal spindle assembly
or if the cells are arrested at a point prior to spindle formation. Several
compounds are known to prevent or disrupt the normal formation of the mitotic
spindle, either by preventing microtubule polymerization (i.e. colchicine, vinca
alkaloids, nocodazole) or stabilizing microtubules and preventing
depolymerization (i.e. taxol) (Rieder and Palazzo, 1992; Johnson and Walker,
1999). However, these compounds generally tend to disrupt normal spindle
organization and arrangement but do not prevent spindle assembly (Jordan et al.,
1992). Colchicine and related compounds have been shown to completely inhibit
formation of spindle microtubules when applied before nuclear envelope
breakdown (NEB), but these cells typically progress through NEB into
prometaphase where the chromosomes become dispersed throughout the
cytoplasm (Rieder and Palazzo, 1992). Moasser et al. (1999) observed a similar
mitotic arrest to that seen in our study by the tyrosine kinase inhibitor PD173955.
They observed cells that appeared to be arrested in prophase, with condensed
chromatin but no spindle apparatus. The mechanism behind this effect was not
clear, but thought to be related to the inhibition of one or more protein kinases.
The cell cycle arrest observed in our study could be due to a similar effect on
kinase activity, or a number of other factors involved in cell cycle regulation.
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Microtubules and microfilaments of interphase cells did not appear to be
affected by either extract. Other compounds that induce intramyelinic edema
have not been fully evaluated for their effects on microtubules or other
cytoskeletal components. Zucker et al. (1989) did not examine effects on
microtubules or the mitotic spindle in their study revealing G2/M phase arrest with
TET, and no other literature is available on the effects of TET on microtubules.
Chow and Orrenius (1994) and Marinovich et al. (1990) found no effects of TET
on F-actin in rat thymocytes and human neutrophils, respectively. Microfilaments
did not appear to be affected by the extracts in our study at the applied
concentration, but there is a possibility that higher doses may have had deleterious
effects.
If the observed cell cycle arrest is induced by the causative agent of AVM,
it is unclear how that effect may relate to the in vivo consequences of
intramyelinic edema. The mechanisms of action of TET, hexachlorophene
(HCP), and other compounds resulting in intramyelinic edema are not fully
known (van Gemert and Killeen, 1998). TET, HCP, and bromethalin have been
shown to affect cellular respiration, as uncouplers of oxidative phosphorylation
(Moore and Brody, 1961; Cammer and Moore, 1972; Aldridge et al., 1977;
Kauppinen et al., 1988; van Lier and Cherry, 1988), and TET has been shown to
affect calcium homeostasis in vitro in several cell lines (Ade et al., 1996; Viviani
et al., 1996; Kauppinen et al., 1998; Jan et al., 2002; Jiann et al., 2002; Lu et al.,
2003). However, it is not yet clear how these effects may relate to the formation
of vacuoles in the myelin sheath. Both TET and HCP are known to bind directly
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to myelin as well as affect levels of myelin basic protein, which is though to play
a role in myelin compaction (O’Callaghan and Miller, 1989; Veronesi et al., 1991;
Amacher and Schomaker, 1994; van Gemert and Killeen, 1998).
As demonstrated in this study and elsewhere (Zucker et al., 1989), TET
causes an arrest of cells in G2/M in vitro, but the mechanism has not been
elucidated and it is not known whether similar effects would be observed on cells
in vivo. Research on the in vivo effects of other anti-proliferative compounds is
usually focused on the treatment of cancerous cells which are rapidly dividing.
After development, most cells of the nervous system, including neurons and glia,
are differentiated and post-mitotic. Neural stem cells exist in the adult brain and
can give rise to new neurons, astrocytes, and oligodendrocytes, but rapid
proliferation of cells generally occurs only after injury (Gage, 2002). The rapid
proliferation of astrocytes in response to toxic insult or other injury is well
documented, but there is conflicting evidence as to whether this astrogliosis
occurs in intramyelinic edema (Tripeir et al., 1981; O’Callaghan and Miller, 1989;
Freeman et al., 1994; van Gemert and Killeen, 1998). Thomas et al. (1998)
reported astrogliosis in one of three eagles examined with AVM in the original
description of the disease, but no other reports of astrocyte involvement have been
reported in AVM studies.
The effect of TET on the cell cycle does not seem to be specific to a
certain cell type, as erythroleukemic (Zucker et al., 1989) and glial cells (this
study) are affected in a similar manner. It is not clear whether or not similar
effects of cell cycle arrest would have been seen in the other cell lines examined
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for cytotoxicity in this study. Morphological observations of these cells revealed
a mild rounding effect evident in both AVM-positive and AVM-negative extracts,
but it is not known whether this rounding represented mitotic cells or cells
undergoing apoptotic or necrotic cell death.
The C6 cell line is derived from a glioma and is astrocytic in origin, but
the effect on C6 cells in this study may represent a general cytotoxic effect rather
than a glial or astrocyte-specific toxicity. Established cell lines can provide
indications of general cytotoxic effects as well as effects on cell division, but
effects on specific cell types are usually studied using primary cultures (Mead and
Pentreath, 1998). This is due to the fact that established cultures, being either
transformed or developed from tumors, may no longer retain all of the original in
vivo characteristics of that cell type (Zucco et al., 1998). Astrocyte-specific
toxicity is usually studied in primary cultures; and the expression of glial fibrillary
acidic protein (GFAP), an intermediate filament specific to astrocytes, has been
shown to be the most sensitive indicator of astrocyte-specific toxicity (Cookson
and Pentreath, 1994). C6 cells have been shown to respond similarly to primary
astrocytes in cytotoxicity assays as well as measures of GFAP but only after
pretreatment with dibutyryl cyclic AMP (Cookson et al., 1995).
The involvement of astrocytes in intramyelinic edema is debated. In vivo
studies have generally found no apparent involvement of astrocytes, although one
study did describe astrocytic swelling (van Gemert and Killeen, 1998). TET has
been studied in vitro for its effects on GFAP expression in primary astrocytic
cultures with conflicting results. Two studies found that while TET induced cell
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death in these cultures, GFAP expression was either not affected at cytotoxic
concentrations (Mead and Pentreath, 1998) or decreased in parallel with
cytotoxicity (Rohl et al., 2001), while another found an increase in GFAP
expression at sub-cytotoxic concentrations (Richter-Landsberg and Besser, 1994).
The other endpoints examined in this study – cytotoxicity and induction of
apoptosis – did not provide significantly different results for the AVM-positive
and AVM-negative extracts. Both extracts resulted in a concentration-dependent
cytotoxicity in all cell lines examined. The AVM-positive extract (Parksville-A)
was slightly more toxic to N2a and QNR/D cells than the AVM-negative (Potato
Creek-B) extract, but it is important to remember that the extracts tested were in
crude form and contained a large number of compounds associated with the
vegetation and epiphytic communities present. The concentrations were
normalized based on the dry weight of extracted vegetation and therefore do not
provide a measure of any bioactive compounds present. It is possible that the
additional presence of the AVM causative agent in the Parksville-A extract was
the source of the additional toxicity; but it is equally as possible that the
Parksville-A extract contained more of the cytotoxic substance or substances
associated with the Potato Creek-B extract. These assays may be able to detect
the AVM toxin in a more purified extract, and could be revisited when such
extracts are produced.
The mechanism of cell death associated with the extracts did not appear to
differ between the AVM-positive (Woodlake, Parksville-A) and AVM-negative
samples (Potato Creek-A) tested, and neither appeared to induce apoptosis at the
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concentrations and time points examined. The high doses of AVM-positive
extracts appeared to induce a fairly acute necrotic cell death, as the number of PI
stained cells in the Annexin assay and the size of the sub-G1 peak in the cell cycle
assay increased with these doses up to 24 h. These doses did not produce an
increase in caspase activity or Annexin V binding prior to cell death and thus
appear to have undergone necrosis. Populations of cells exposed to the lower
doses of AVM-positive extracts and the AVM-negative extracts did not have
appreciable cell death by 24 h. It is unclear what the ultimate fate of the cells
blocked in G2/M may be. At lower doses of some extracts (SCWMA, ParksvilleB, Woodlake, Petersburg) the cell populations appear to recover by 24 h. In
extracts where there is a continued G2/M phase block at 24 h (Dens Swamp,
Parksville-A), it is likely that these cells proceeded to undergo apoptotic or
necrotic cell death at a later time point. There are reports of both apoptotic and
necrotic cell death following cell cycle arrest induced by other compounds in
various cell lines (Fujikawa-Yamamoto et al., 1994; Subbegowda and Frommel,
1998; Butler et al., 2000). TET is known to induce apoptosis in primary
oligodendrocytes, hippocampal and cortical neurons (Thompson et al., 1996;
Stahnke and Richter-Landsberg, 2004), but the effects of other inducers of
intramyelinic edema on the mechanism of cell death in vitro has not been
evaluated. Two other organotin compounds, triphenyltin and tributyltin, have
been shown induce apoptosis in several cell lines at low concentrations but result
in necrosis at higher doses (Stridh et al., 1999) with triphenyltin also inducing cell
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cycle arrest in G2/M at concentrations shown to induce apoptosis (Chikahisa et al.,
1998).
The cell cycle arrest as measured by flow cytometry analysis of DNA
content appears to be a promising assay in the detection of the AVM toxin.
However, it is not yet clear whether the mitotic block associated with the AVMpositive extracts is in fact due to the AVM causative agent and further
fractionation and clean up of the crude extracts is necessary to isolate the AVM
toxin for future testing. In future examinations with this assay, the 4 h time point
may be sufficient to observe any significant results, as this time point appears to
be the most sensitive in detecting the cell cycle disruption and as the activity
associated with lower concentrations of extract is lost by 24 h. This may be due
to a decrease in cell division rate at the later time points, as Rouzaire-Dubois et al.
(2000, 2004) have shown that C6 cell proliferation slows as cells approach
confluency. In addition, since the effects on the cell cycle observed in this study
were concentration-dependent, a range of dosages should be included to minimize
the chance of missing any possible activity.
The extraction procedure developed in Chapter 2 (Wiley, 2007) coupled
with the discovery of the cell cycle disruption observed here provide promising
tools in the future study of AVM pathology and the search for the causative agent
of this disease.

If the cell cycle assay can be validated as a means of detecting

the AVM toxin it can then be used to guide toxin fractionation and isolation
studies, provide an alternative to in vivo assays, and provide a model to begin
investigating mechanism of action.
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CHAPTER 4
IN VIVO AND IN VITRO TOXICITY OF FRACTIONS PRODUCED FROM A
CRUDE EXTRACT OF HYDRILLA VERTICILLATA AND ASSOCIATED
EPIPHYTES COLLECTED DURING AN AVM EPIZOOTIC

Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting
bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana) and
other birds in the southeastern U.S. The cause of AVM is unknown, though it is
suspected to be a biotoxin and has been linked to ingestion of aquatic vegetation.
AVM is associated with a number of reservoirs in five southeastern states, and to
date had been responsible for the deaths of over 100 bald eagles and thousands of
coots (Wilde et al., 2005).
AVM is characterized and diagnosed by a spongy degeneration of the
white matter of the central nervous system. Multiple vacuoles of varying severity
are seen throughout the white matter of the brain and spinal cord, being
particularly prominent in the optic tectum (Thomas et al., 1998). Birds with
AVM may display clinical signs of neurological impairment, such as difficulty in
flying, swimming, and/or walking, but not all birds with AVM lesions display
clinical signs, and clinical recovery has been documented despite the persistence
of lesions (Larsen et al., 2002).

AVM has been linked to the ingestion of aquatic vegetation, with several
studies demonstrating induction of AVM in laboratory animals after ingestion of
aquatic vegetation (Hydrilla verticillata and associated epiphytes) collected
during AVM epizootics (Birrenkott et al., 2004; Lewis-Weis et al., 2004; Rocke et
al., 2005). As demonstrated by Fischer et al. (2003), predators such as the eagle
contract AVM by feeding on affected prey.
It is not yet clear what factor associated with the vegetation causes AVM,
but researchers have linked the disease to an epiphytic cyanobacterium that grows
on the plant material. Hydrilla that induced AVM in a mallard laboratory study
contained large quantities of a novel cyanobacterial species that covered 50-90%
of the leaf surface area (Birrenkott et al., 2004). Surveys of cyanobacterial and
algal epiphytes revealed the consistent presence of this species, a previously
unknown member of the order Stigonematales, at all known sites of AVM
epizootics (Wilde et al., 2005). The cyanobacterium was present in high
abundance at AVM sites, and was not observed, or observed in low abundance, at
control sites. It has been hypothesized that this species is producing a neurotoxin
responsible for AVM.
We have been successful at extracting the AVM toxin from vegetation
collected during an AVM epizootic (Wiley, 2007, Chapter 2). This study
produced a crude methanol extract that induced AVM in laboratory mallards upon
exposure by oral gavage. This crude extract, along with several other extracts
produced from various sites of AVM outbreaks, also induced cell cycle arrest in
C6 glioma cells (Wiley, 2007, Chapter 3). The in vitro effects could not be
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directly attributed to the AVM toxin, as the extracts were still in crude form and
may have contained a variety of bioactive compounds associated with the
vegetation or the epiphytic communities present. As well, extracts from
vegetation collected at sites having no previous history of AVM also induced a
mild cell cycle arrest.
The objectives of this study were to further fractionate a crude methanol
extract to advance the isolation of the AVM toxin, as well as evaluate the
effectiveness of the in vitro cell cycle assay at detecting the toxin. Crude extract
was produced from vegetation collected during an AVM epizootic by methods
developed in Chapter 2 (Wiley, 2007). Several fractions covering a full range in
polarity were then isolated from this crude extract by liquid-liquid extraction as
well as C18 solid phase extraction (SPE), and evaluated for toxicity by an in vivo
chicken bioassay and the in vitro cell cycle analysis.

Materials and Methods
Preparation of Crude Extract
Crude methanol extracts were produced using methods developed in
Chapter 2. Aquatic vegetation (Hydrilla verticillata and associate epiphytes) was
collected from Woodlake, North Carolina 22 November 2005 during an AVM
epizootic. Control hydrilla was collected 14 October 2003 from Potato Creek
Embayment, Lake Marion, South Carolina, a reservoir with no known history of
AVM. Hydrilla was lyophilized, blended to a coarse powder, and dry weight was
recorded (Potato Creek, 605.4 g; Woodlake, 1121.1 g). Dried, powdered
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vegetation was loaded evenly into two, 2 L separatory funnels and sequentially
extracted with hexanes, acetone and methanol (Fisher Chemical, HPLC grade,
Fischer Scientific, Hampton, New Hampshire, USA). Solvent was added to the
vegetation until saturated (1-1.5 L of solvent per funnel) and the sample was
mechanically extracted by shaking for five, 2 min periods over 1 h. The extract
was then allowed to drain, and the sample was rinsed with a final volume of
solvent (0.5 L). Drained solvents were pooled. This process was then repeated
with the next solvent. Hexanes and acetone extracts were discarded. The
methanol extracts were filtered through 70 mm Whatman qualitative grade filter
paper (Whatman, Inc., Florham Park, New Jersey, USA) to remove particulates,
and solvent was removed by a rotary evaporator (Buchi Rotavapor, Buchi, Flawil,
Switzerland) with a water bath set no higher than 28°C. When dry, the extracts
were re-suspended in the appropriate volume of methanol to a concentration of 10
g vegetation/ml solvent, based on the initial dry weight of the vegetation. Half of
the Potato Creek crude extract was archived at -20°C for use in in vitro studies
and half was stored at -20°C for the chick study. One-third of the crude
Woodlake extract was stored at -20°C for the chick study, of which 20% was
archived for in vitro studies. The remaining two-thirds of Woodlake crude extract
was further fractionated as described below.

Preparation of Extract Fractions
Woodlake crude extract was brought to 90% methanol with deionized
water and extracted 10x with hexanes to remove chlorophylls. Hexanes fractions
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were pooled. The aqueous methanol fraction was then centrifuged at 3500 rpm
for 10 min to remove particulates. The pellet was washed twice with 90%
methanol. Supernatants were pooled and split in half. One-half of the
supernatant was brought to 60% methanol and extracted 3x with methylene
chloride. The remaining half of the supernatant was dried by rotary evaporator
and re-suspended in 100% HPLC water for C18 SPE. Prior to running through
the C18 column, the extract was filtered through 70 mm Whatman qualitative
grade filter paper to remove a significant amount of particulates that did not resuspend in the HPLC water. These particulates were re-suspended in 100%
methanol and archived at -20°C for potential future testing. The dissolved
fraction was run through a C18 SPE column (Varian BondElut C18 SPE column,
Varian, Inc., Palo Alto, California, USA) and eluted with HPLC water; 25%
methanol; 50% methanol; 75% methanol; 100% methanol; acetone; methylene
chloride; and hexanes (Figure 18). All resulting fractions were concentrated by
rotary evaporator and/or lyophilization and re-suspended to 10 g vegetation/ml
solvent, based on the initial dry weight of the vegetation. Twenty percent of each
fraction was archived at -20°C for in vitro testing and the remaining 80% was
stored at -20°C until use in the chick study.
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Figure 18. Fractionation of the crude methanol extract produced from vegetation collected from Woodlake, North Carolina during an
AVM epizootic. MeOH=methanol. MeCl2=methylene chloride.

Chick Bioassay
Forty-two, nine-day-old chicks were obtained from the Clemson
University Morgan Poultry Center and transported to Godley-Snell Research
Center at Clemson University. Chicks were banded with wing tags for
identification and housed in a single-cage commercial brooder. Food and water
were provided ad libitum. Chicks were acclimated four days prior to initiation of
the treatment period.
Chicks were randomly assigned to experimental groups, with three birds
per group. Treatments were administered by oral gavage three times a week for
two weeks. Dose volumes were based on body weight at the time of dosing, at
0.00646 ml/g b.w. and 10 g hydrilla/ml. This concentration is based on the
concentration given to mallards developing AVM in a previous study (Wiley,
2007, Chapter 3).

Birds were observed twice daily for any sign of neurological

impairment or distress. At the end of the two-week treatment period, birds were
euthanized by CO2 asphyxiation. Whole brains were removed, weighed, and
fixed in 10% neutral buffered formalin. Brains were evaluated for AVM lesions
at the Southeastern Cooperative Wildlife Disease Study, Athens, Georgia by
methods previously described (Fischer et al., 2003).

Cell Bioassay
C6 cells were obtained from the American Type Culture Collection
(ATCC). Cells were maintained at 37°C with 5% CO2 in Kaighn’s modification
of Ham’s F12 medium with 2mM L-glutamine modified to contain 1.5 g/L
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sodium bicarbonate and supplemented with 15% horse serum and 2.5% fetal
bovine serum. Cells were routinely passaged twice weekly and cells in passages
5-30 were used in assays. All cells were grown in the absence of antibiotics.
Cell cycle analysis was conducted by measuring the DNA content of cells
with propidium iodide. C6 cells were plated at ~5x105/ml in 6-well plates at 2 ml
per well and allowed to attach overnight. Cells were exposed to all fractions at
12.5, 50, and 100 mg/ml, as well as a vehicle control (methanol). Following
exposure for 4 h, cells were harvested with trypsin-EDTA, pelleted by
centrifugation at 3500 rpm for 5 min, and fixed in ice-cold 70% ethanol overnight
at -20°C. Cells were then pelleted (3500 rpm, 5 min, room temperature) and
stained with 10 Vg/ml propidium iodide in PBS containing 10 Vg/ml RNase for 1h
at room temperature in the dark. Flow cytometry analysis for cell cycle
distribution was conducted on a Coulter EPICS XL with excitation at 488 nm and
an emission wavelength of 635 nm. A minimum of 10,000 cells were counted for
each sample. The percentage of cells in G1, S, and G2/M phases were calculated
using Multicycle software (Phoenix Flow Systems, San Diego, California, USA).
The experiment was repeated with three independent culture preparations and the
percentages of cells in each phase were compared by a one-way ANOVA
followed by Tukey’s multiple comparison test as performed by GraphPad Prism
software (v 5.00, GraphPad Software, Inc., San Diego, California, USA).
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Results
Chick Bioassay
No clinical signs of neurological disease or other signs of impairment or
distress were noted during the study and all chicks steadily gained weight, though
there were differences in weight gain among treatment groups (Figure 19). Birds
dosed with Woodlake crude extract gained significantly less weight during the
study than those dosed with Potato Creek crude extract, as well as those dosed
with hexanes, particulates, C18 hexanes, and C18 50% MeOH fractions.
No definitive AVM-type lesions were seen in the chick brains. There
were a few brains with mild white matter lesions, consisting of a low number of
vacuoles located in the optic lobe, brainstem, cerebral white matter and/or
cerebellar folia. These mild lesions were seen in one bird given Woodlake crude
extract, two birds given the MeCl2 fraction, and one bird each given the hexanes,
C18 H20, and C18 100% MeOH fractions. The bird exposed to the Woodlake
crude extract had non-definitive AVM-like lesions, with diffuse tiny vacuoles
present throughout the outer white matter layer of the optic lobe (Figure 20).
Inflammatory lesions were also present in six brains that were indicative of a viral
infection, but not associated with AVM. Brain slides are archived at the Marine
Resources Research Institute, South Carolina Department of Natural Resources,
Charleston, South Carolina, USA.

119

200

grams

150

*

100

50

Po
ta
to
C
W ree
L
k
C
ru
He de
xa
ne
M s
Aq eCl
2
Pa Me
O
rt
C1 icu H
8 la te
He s
x
C1 an
8 e
C1 M s
C1 8 e C
A
l2
8
10 ce
t
o
0
C1 % n
8
M e
75 e
C1 % O
H
8
M
50 eO
C1 %
H
8
M
25 eO
%
H
M
eO
C1 H
8
H2
0

0

Figure 19. Average weight gain of chicks by treatment group from the initiation
of the study to euthanasia. Data are represented as means ± SEM.
(WL=Woodlake). Asterisk represents significant difference from Potato Creek
treatment, with a p-value of c 0.05.
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Figure 20. Mild white matter lesions in chickens exposed to a Woodlake crude
extract and fractions produced from that crude extract: (A) C18 H20; (B) Hexanes;
(C); MeCl2; (D) MeCl2; (E) Crude; (F) C18 100% MeOH. Vacuoles can be seen
in various white matter tracts (arrows).
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Figure 20. Mild white matter lesions in chickens exposed to a Woodlake crude
extract and fractions produced from that crude extract: (A) C18 H20; (B) Hexanes;
(C); MeCl2; (D) MeCl2; (E) Crude; (F) C18 100% MeOH. Vacuoles can be seen
in various white matter tracts (arrows) (Continued).
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Figure 20. Mild white matter lesions in chickens exposed to a Woodlake crude
extract and fractions produced from that crude extract: (A) C18 H20; (B) Hexanes;
(C); MeCl2; (D) MeCl2; (E) Crude; (F) C18 100% MeOH. Vacuoles can be seen
in various white matter tracts (arrows) (Continued).
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Cell Bioassay
Significant cell cycle arrest in G2/M phase was observed in two fractions.
The percentages of cells in each phase are shown in Figure 21. The C18 100%
MeOH fraction caused a significant 3-fold increase in G2/M cells at 100 mg/ml
and a significant 2-fold increase at 50 mg/ml, with concomitant decrease of G1
cells. The MeCl2 fraction caused a significant 3-fold increase in G2/M cells at
12.5 mg/ml and a 2-fold, but not significant increase at 50 and 100 mg/ml. There
were no other significant differences from control populations.

124

100 mg/ml
70

% of cells

60
50

G1

40

S

*

30

G2/M

20
10

C
on
H trol
ex
an
e
M s
eC
Aq
l2
Pa Me
rt O
C icu H
18 la
H tes
e
C xan
18
e
C
M s
1
e
C
18 8 A Cl2
c
10 et
C 0% one
18
M
75 eO
C
18 % M H
5
e
C 0% OH
18
25 Me
% OH
M
e
C OH
18
H2
0

0

50 mg/ml
70

% of cells

60
50

G1

40

S

30

G2/M

*

20
10

Co
n
H trol
ex
an
e
M s
e
Aq Cl2
Pa Me
rt O
C icu H
18 la
He tes
C xan
18
es
C
M
C 1 8 eC
18
l2
A
10 cet
o
C 0% ne
18
M
e
7
C 5 % OH
18
M
e
5
C1 0% OH
8
M
25 eO
%
H
M
eO
C
18 H
H
20

0

Figure 21. Cell cycle distribution of C6 cells exposed to fractions produced from
the Woodlake crude extract at 100, 50 and 12.5 mg/ml and a vehicle control
(methanol only). Data represent means ± SEM for three independent
experiments. Asterisks represent significant difference from control, with a pvalue c 0.05.
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Figure 21. Cell cycle distribution of C6 cells exposed to fractions produced from
the Woodlake crude extract at 100, 50 and 12.5 mg/ml and a vehicle control
(methanol only). Data represent means ± SEM for three independent
experiments. Asterisks represent significant difference from control, with a pvalue c 0.05 (Continued).

Discussion
The goal of this study was to fractionate the crude methanol extract in an
attempt to further isolate the AVM toxin, thereby gaining more information on the
physicochemical properties of the toxin as well as gaining further evidence that
the cell cycle arrest observed with the crude extracts in Chapter 3 (Wiley, 2007)
could be attributed to the toxin. In vitro analysis revealed significant cell cycle
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arrest in two fractions of intermediate polarity: the MeCl2 fraction produced from
liquid-liquid extraction and the 100% MeOH fraction produced from C18 SPE.
Unfortunately, the presence of the AVM causative agent in these fractions could
not be confirmed because the results of the chick bioassay were inconclusive.
Mild white matter lesions were present in two of three chicks brains administered
the MeCl2 fraction and one of three birds administered the C18 100% MeOH
fraction. However, mild lesions were also seen in one of three birds administered
both the hexanes fraction and the C18 H20 fraction, which had no effect on the
cell cycle.
The crude extract produced from the vegetation resulted in mild white
matter lesions in only one of three birds tested. Therefore, the fact that the
fractions did not produce definitive lesions is not likely due to the fractionation
procedure but some other issue. The fractionation procedure did efficiently
isolate the toxic activity associated with the cell cycle arrest. The MeCl2 fraction
induced cell cycle disruption at the same concentration as the crude extract, which
also significantly arrested the cells in G2/M at 12.5 mg/ml (Wiley, 2007, Chapter
3), suggesting that the liquid-liquid fractionation did not result in a loss of
toxicity. Some toxicity associated with cell cycle arrest was lost with the C18
SPE procedure, as the C18 100% MeOH fraction did not induce cell cycle
disruption below 50 mg/ml. This may due to the fact that the extract was resuspended in 100% water prior to running through the SPE column and a portion
of the extract did not dissolve in this solvent. Re-suspending the extract in 2550% methanol in water may work more efficiently for future procedures using
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C18 columns. Despite the observed in vitro effects, the effectiveness of the
fractionation procedure at isolating the AVM toxin is unknown and will need
future study.
Birds exposed to Woodlake crude extract had significantly lower weight
gain on average than birds given Potato Creek extract. Decreased weight gain in
AVM-affected birds has not been previously noted in other AVM studies
involving chickens (Lewis-Weis et al., 2004). However, studies with triethyltin
and hexachlorophene have reported decreased weight gain in rats and mallard
ducklings exposed to concentrations producing intramyelinic lesions (Beirkamper
and Valdes, 1982; Kung et al., 1988; Fleming et al., 1991). Since the brain results
were inconclusive, it is impossible to say whether or not the decreased weight
gain in this group was due to exposure to the AVM toxin. Several other treatment
groups also had decreased weight gain compared to the Potato Creek group,
including the aqueous methanol, C18 MeCl2 and C18 Acetone groups, but those
results were not significant and these fractions did not produce any toxic effects in
vitro.
There are several possible explanations for the inconclusive results
obtained in this study, including insufficient toxin concentration in the extracted
vegetation, an insufficient period of exposure, an inappropriate animal model, or a
combination of these factors. The vegetation extracted in this study was collected
from Woodlake during an AVM epizootic in which large numbers of American
coots were diagnosed with the disease (Wilde, unpubl. data). However, the
vegetation was not tested by mallard bioassay prior to this study to confirm AVM
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toxin presence and it is possible that the toxin was no longer present at the time of
our collections (or present but at a low concentration). Coots are able to survive
for several weeks after AVM lesion formation (Larsen et al., 2002), so the AVMaffected birds that were observed on Woodlake during our collections could have
been exposed to the causative agent weeks earlier. Rocke et al. (2005) and Larsen
et al. (2003) failed to induce AVM in laboratory mallards after exposure to
hydrilla collected from Woodlake while affected coots were present. There may
be a short window of toxin production and persistence in these reservoirs that is
not directly correlated with the presence of affected birds. It is also possible that
the toxic agent is not evenly distributed throughout the vegetation and the samples
that were collected in these studies happened to contain low concentrations.
Another possible explanation for the inconclusive results in this study is
that the exposure time was insufficient to produce effects. Previous laboratory
and field studies have shown that birds can develop lesions within two weeks of
exposure to the causative agent of AVM, with five days being the earliest known
onset. However, this data was discovered only after the birds displayed clinical
signs of AVM (Rocke et al., 2002; Wiley, 2007, Chapter 1) or after birds were
euthanized due to unrelated reasons, as with the bird whose wing was broken in
the mallard extract study (Wiley, 2007, Chapter 2). The only laboratory study
undertaken with the goal of exploring the onset of AVM lesion formation was not
successful since none of the birds developed AVM (Wiley, 2007, Chapter 1).
Therefore, it is not clear whether all birds developing AVM experience quick
lesion onset after an acute exposure, or whether some birds may develop the
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disease after more chronic, low level exposure to the causative agent. Studies
with triethyltin and hexachlorophene describe a concentration-dependent timing
of vacuole formation in mice and rats in acute studies, with a single i.p. or i.v.
injection and vacuole formation observed up to 30 h following exposure (Jacobs
et al., 1977; Tripier et al., 1981). Both acute and chronic experiments have been
conducted with these chemicals, but the time of lesion formation in more chronic
experiments has not been evaluated.
A final possibility concerning the absence of definitive AVM lesions may
be that the chickens are not a suitable animal model for studying AVM toxicity.
Chickens were selected as the animal model for this research due to their smaller
body weight and lower tendency to regurgitate after gavage compared to adult
mallards, which have been the standard animal model used in our laboratory.
Chickens are also more readily available and easy to obtain than mallards. Adult
mallards were used as the animal model in the previous study involving the
gavage of crude vegetative extract (Wiley, 2007, Chapter 2). This study was
successful at inducing AVM lesions in these birds, but required extensive
preparation time due the large quantities of vegetation that had to be lyophilized
and extracted. In addition, mallards frequently regurgitated the administered
material after gavage. Although the birds did subsequently develop AVM lesions,
it was felt that an animal model less apt to regurgitate would be more appropriate.
Young chickens had been used successfully as animal models in a previous AVM
study (Lewis-Weis at al., 2004), and it was thought that these birds would provide
a suitable model for this research. However, while Lewis-Weis et al. revealed

130

that chickens are susceptible to AVM, the relative sensitivity of chickens to the
AVM agent compared to other birds is unknown.
Any or all of the above mentioned factors could be responsible for the
failure to induce AVM lesions in the chicks. Unfortunately there are still many
unanswered questions concerning this disease and we can only speculate as to
which variables may have played a role. Although the fractionation procedure
used in this study successfully isolated the in vitro toxicity associated with the
extracts, these effects cannot be attributed to the AVM toxin due to the absence of
definitive lesions in the chicks. Further studies are therefore needed to validate
both the fractionation procedure and the in vitro assay.
It is recommended that future experiments should be conducted for at least
four weeks, with vegetation that is first confirmed to contain the AVM toxin by
mallard bioassay. Although these measures will increase the time and cost
involved for both extract preparation and the animal trials, they will help
eliminate some of the frustrating questions that have arisen with this study. The
use of another animal model such as mallards should also be considered, although
the problems associated with doing such a study with mallards (amount of
vegetation, regurgitation concerns, and availability) will have to be taken into
account.
The potential benefits of a successful fractionation procedure and
validated in vitro model to AVM research are undeniable. Toxin isolation and
characterization depend upon this research, as do mechanism of action studies.
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Hopefully the results obtained in this study and the issues that have arisen in
interpreting those results will aide future research efforts in this area.
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CHAPTER 5
ORAL ADMINISTRATION OF AN EXTRACT OF HYDRILLA
VERTICILLATA CONTAINING THE ETIOLOGIC AGENT
OF AVM TO A MOUSE MODEL

Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease primarily
affecting bald eagles (Haliaeetus leucocephalus) and American coots (Fulica
americana) in the southeastern U.S. The cause of AVM is unknown, though it is
suspected to be a biotoxin and has been linked to ingestion of aquatic vegetation.
AVM is associated with a number of reservoirs in five southeastern states, and to
date had been responsible for the deaths of over 100 bald eagles and thousands of
coots (Wilde et al., 2005).
AVM is characterized and diagnosed by a spongy degeneration of the
white matter of the central nervous system. Multiple vacuoles of varying severity
are seen throughout the white matter of the brain and spinal cord, being
particularly prominent in the optic tectum (Thomas et al., 1998). Birds with
AVM may display clinical signs of neurological impairment, such as difficulty in
flying, swimming, and/or walking, but not all birds with AVM lesions display
clinical signs, and clinical recovery has been documented despite the persistence
of lesions (Larsen et al., 2002).

AVM has been linked to the ingestion of aquatic vegetation, with several
studies demonstrating induction of AVM in laboratory animals after ingestion of
aquatic vegetation (Hydrilla verticillata and associated epiphytes) collected
during AVM epizootics (Birrenkott et al., 2004; Lewis-Weis et al., 2004; Rocke et
al., 2005). As demonstrated by Fischer et al. (2003), predators such as the eagle
contract AVM by feeding on affected prey.
It is not yet clear what factor associated with the vegetation is the source
of AVM, but researchers have linked the disease to an epiphytic cyanobacterium
that grows on the plant material. Hydrilla that induced AVM in a mallard
laboratory study contained large quantities of a novel cyanobacterial species that
covered 50-90% of the leaf surface area (Birrenkott et al., 2004). Surveys of
cyanobacterial and algal epiphytes revealed the consistent presence of this
species, a previously unknown member of the order Stigonematales, at all known
sites of AVM epizootics (Wilde et al., 2005). The cyanobacterium was present in
high abundance at AVM sites, and was not observed, or observed in low
abundance, at control sites. It has been hypothesized that this species is
producing a neurotoxin responsible for AVM.
The list of susceptible species is currently confined to birds, and in
addition to bald eagles and coots, includes mallards (Anas platyrhynchos), ringnecked ducks (Aythya collaris), buffleheads (Bucephala albeola), Canada geese
(Branta canadensis), great-horned owl (Bubo virginianus), and killdeer
(Charadrius vociferus). Red-tailed hawks (Buteo jamaicensis) and domestic
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chickens (Gallus domesticus) have also been shown to be susceptible in
laboratory studies.
AVM lesions have never been confirmed in mammals during AVM
epizootics, though there has been anecdotal evidence of possible clinical signs in
a beaver (Castor canadensis) (Lewis-Weis et al., 2004). Several mammals were
collected during AVM outbreaks on J. Strom Thurmond Lake, a reservoir located
on the South Carolina/Georgia border, over the last few years, including beavers,
raccoons (Procyon lotor) and a gray fox (Urocyon cinereoargenteus). Definitive
AVM lesions were not found in their brain tissue, despite the fact that coot tissue
was discovered in the stomach contents of one raccoon and the fox (Fischer et al.,
2006).
There have been several laboratory studies to examine mammalian
susceptibility to AVM. Swine failed to develop lesions when fed AVM-affected
coot tissue, though the authors note that the duration of exposure and quantity of
ingested material may not have been sufficient to induce disease (Lewis-Weis et
al., 2004). Mice fed hydrilla collected during AVM events also failed to develop
lesions (Rocke et al., 2005; Birrenkott, unpubl. data); however, these animals did
not appear to consume much, if any, of the vegetation in at least one study
(Birrenkott, unpubl. data). It is also possible that the vegetation may not have
contained the causative disease agent in sufficient quantities to induce disease.
Due to the potential health implications for humans consuming affected
waterfowl or otherwise coming into contact with the AVM toxin, as well as the
potential for mammalian wildlife to be affected, mammalian susceptibility to the
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AVM toxin needs further exploration. We have recently been successful at
extracting the AVM toxin from vegetation collected during an AVM epizootic
(Wiley, 2007, Chapter 2). This study produced a crude methanol extract that
induced AVM in laboratory mallards upon exposure by oral gavage. The current
study utilized archived extract from the successful mallard study in an attempt to
induce AVM in laboratory mice. By delivering the known toxic extract by oral
gavage, this study ensures that the mice are exposed to an active toxin in a
concentrated form, giving a better indication of mammalian susceptibility than
previous studies.
In addition to administering the crude methanol extract, a portion of the
extract was further fractionated and those fractions were tested by the mouse
model as well as an in vitro assay. Further fractionation of the crude extract and
the development of an in vitro assay for detection of the AVM toxin would
greatly benefit AVM research. The crude extract had been previously shown to
induce cell cycle arrest in C6 glioma cells (Wiley, 2007, Chapter 3), and the cell
cycle assay is a potentially useful means of detecting the AVM toxin. However,
the cell cycle arrest could not be directly attributed to the AVM toxin as the
extract was in crude form and may have contained a variety of bioactive
compounds associated with the vegetation or the epiphytic communities present.
Therefore, in the hopes of further validating the assay, all fractions produced from
the crude extract were tested by the cell cycle assay in addition to the mouse
model.
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Materials and Methods
Preparation of Crude Extracts
Crude extracts were produced in a previous study (Wiley, 2007, Chapter
2). Briefly, aquatic vegetation (Hydrilla verticillata and associated epiphytes)
was collected from an AVM-positive site (Parksville Cove, J. Strom Thurmond
Lake, South Carolina, USA) and a control site with no previous history of AVM
(Potato Creek Embayment, Lake Marion, South Carolina, USA) and presence or
absence of the AVM causative agent was confirmed by an ad libitum mallard
feeding study using half of the collected material (Wiley, 2007, Chapter 2). The
remaining half of the vegetation was extracted as follows. Vegetation was
lyophilized, blended into a coarse powder, and sequentially extracted using a
series of solvents: hexanes, acetone, and methanol. Extracts were filtered and
concentrated, and ten percent was archived for future use. The remaining 90%
was used in a mallard gavage study to determine which extracts contained the
AVM toxin. Results from the study showed that the methanol extract contained
the active toxin, as all three birds exposed to the extract developed white-matter
lesions consistent with AVM. The archived methanol extracts of control and
AVM-positive hydrilla were used in the present study. Prior to dosing, solvent
was evaporated by N2 stream and extracts were re-suspended in a 90:10 solution
of DI water:propylene glycol to a concentration of 10 g hydrilla/ml vehicle.
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Preparation of Extract Fractions
The AVM-positive crude methanol extract was further fractionated for the
present study (Figure 22). A portion of the crude methanol extract was brought to
90% methanol with deionized (DI) water and extracted 12x with an equivalent
volume of hexanes to remove chlorophylls. Hexanes fractions were pooled. The
aqueous methanol fraction was then centrifuged to remove particulates by
spinning at 3600 rpm for 10 min. The pellet was washed 3x with 90% methanol
and supernatants were pooled. The supernatant was brought to 60% methanol
with deionized water and extracted 3x with methylene chloride. Methylene
chloride fractions were pooled. Hexanes, methylene chloride, and aqueous
methanol fractions were reduced by rotary evaporator, N2 stream, and/or
lyophilizer and re-suspended in a 90:10 solution of DI water: propylene glycol to
a concentration of 10 g hydrilla/ml vehicle. Particulates were re-suspended in DI
water to a concentration of 10 g/ml.

Mouse Bioassay
Nineteen male ICR mice (25-34 g, Harlan, Indianapolis, Indiana, USA)
were received 4 April 2006 and housed three per cage by experimental group,
with one extra mouse housed separately. Individuals were identified by ear
punch. Animals were acclimated for six days prior to treatment and received
commercial feed and water ad libitum throughout the study. The six experimental
groups (three mice per group) consisted of the control and AVM-positive crude
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Figure 22. Fractionation of crude methanol extract containing the active AVM
toxin. Four fractions result: hexanes, particulates, methylene chloride (MeCl2),
and aqueous methanol (MeOH).

extracts, as well as the four fractions of the AVM-positive extract: hexanes,
particulates, methylene chloride, and aqueous methanol.
Extracts were delivered by oral gavage in five doses over a two-week
treatment period. Dose volumes were based on body weight at the time of dosing,
corresponding to the mallard extract study (0.00646 ml/g b.w. at 10 g
hydrilla/ml). Mice were observed twice daily for signs of neurological
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impairment or other abnormal behavior. Due to the loss of two mice in the
methylene chloride group after the first dose administration (see results), the
nineteenth mouse (an extra) was placed in this group. Since this mouse only
received four doses, each dose was increased to give an equivalent amount as the
other mice. Mice were euthanized by CO2 asphyxiation at the conclusion of the
two-week treatment period. Brains were removed, weighed, and fixed in 10%
neutral buffered formalin. AVM diagnosis was conducted at the Southeastern
Cooperative Wildlife Disease Study (SCWDS) by methods previously described
(Fischer et al., 2003). Liver, kidney, and gastrointestinal tracts were removed and
archived at -20°C.

Cell Bioassay
C6 cells were obtained from the American Type Culture Collection
(ATCC). Cells were maintained at 37°C with 5% CO2 in Kaighn’s modification
of Ham’s F12 medium with 2mM L-glutamine modified to contain 1.5 g/L
sodium bicarbonate and supplemented with 15% horse serum and 2.5% fetal
bovine serum. Cells were routinely passaged twice weekly and cells in passages
5-30 were used in assays. All cells were grown in the absence of antibiotics.
Cell cycle analysis was conducted by measuring the DNA content of cells
with propidium iodide. C6 cells were plated at ~5x105/ml in 6-well plates at 2 ml
per well and allowed to attach overnight. Crude extracts were tested previously in
Chapter 3. Fractions of AVM crude extract were tested at 12.5, 50, and 100
mg/ml. Following exposure at 4 h, cells were harvested with trypsin-EDTA,
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pelleted by centrifugation at 3500 rpm for 5 min, and fixed in ice-cold 70%
ethanol overnight at -20°C. Cells were then pelleted (3500 rpm, 5 min, room
temperature) and stained with 10 Vg/ml propidium iodide in PBS containing 10
Vg/ml RNase for 1h at room temperature in the dark. Flow cytometry analysis for
cell cycle distribution was conducted on a Coulter EPICS XL with excitation at
488 nm and an emission wavelength of 635 nm. The percentage of cells in G1, S,
and G2/M phases were calculated using Multicycle software (Phoenix Flow
Systems, San Diego, California, USA). The experiment was repeated with three
independent culture preparations and the percentages of cells in each phase were
compared by a one-way ANOVA followed by Tukey’s multiple comparison test
as performed by GraphPad Prism software (v 5.00, GraphPad Software, Inc., San
Diego, California, USA).

Results
No signs of neurological impairment were noted during the study. Two
mice (MeCl2 and particulate groups) were euthanized within 2 d of the first dose
administration due to swollen right sides and general lethargy. A third mouse
(MeCl2 group) was found dead the day following the first dose administration.
Two days following the second dose administration, another mouse (MeCl2
group) was found dead after appearing slightly lethargic the previous day. All
four of these mice appeared to have developed infections due to gavage error.
Necropsy revealed that the esophageal tract was punctured during gavage,
allowing the dose solution to enter the thoracic cavity.

143

No white matter lesions characteristic of AVM were seen in any mouse
brains. However, in 10 of the 19 mice there was unusual focal vacuolization with
low numbers of vacuoles within the hippocampus, usually in the molecular layer
adjacent to the pyramidal cell layer (Figure 23) and occasionally in the pyramidal
cell layer. These vacuoles were seen in all experimental groups except the
control, although the number of mice with vacuoles varied among the groups
(Table 11). Upon consultation with several pathologists, it was determined that
these vacuoles may have been an artifact of formalin fixation, though this could
not be confirmed and the fact that the lesions were not seen in control mice raises
suspicions. Brain slides are archived at the Marine Resources Research Institute,
South Carolina Department of Natural Resources, Charleston, South Carolina,
USA.
Results of the in vitro cell cycle analysis are shown in Figure 24. The
MeCl2 fraction of the AVM crude extract caused a significant increase in the
number of cells present in G2/M at 50 and 100 mg/ml. A slight but not significant
increase in G2/M cells was also seen in cells exposed to the hexanes fraction at
100 mg/ml. The control crude extract (tested in Chapter 3, Wiley, 2007), the
particulate fraction and the aqueous methanol fraction did not induce cell cycle
arrest.
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Figure 23. Light micrograph image of the hippocampus of a mouse gavaged with
crude methanol extract from Parksville Cove, J. Strom Thurmond Lake, South
Carolina. Unusual vacuolization is present (arrow).
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Table 11. Presence of hippocampal lesions in mice exposed to extracts of
Hydrilla verticillata and associated epiphytes collected from Potato Creek
Embayment, South Carolina and Parksville Cove, J. Strom Thurmond Lake,
South Carolina.
Experimental Group

Presence of lesions

Potato Creek Crude

0/3

Parksville Crude

2/3

Particulates

3/3

Hexanes

3/3

Methylene Chloride

1/4

Aqueous Methanol

1/3
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Figure 24. Cell cycle distribution of C6 cells after exposure to four fractions
produced from the AVM-positive crude extract at 100, 50 and 12.5 mg/ml. Data
represent means ± SEM from three independent experiments. Asterisks represent
significant difference from control with a p-value c 0.05.
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Discussion
The goal of this study was to evaluate mammalian susceptibility to AVM
by administering a known AVM-positive vegetative extract to mice. Following
two weeks of exposure to the extract at a dosage which induced AVM in
mallards, no mice contained white matter lesions consistent with vacuolar
myelinopathy. Therefore it appears that mice are not susceptible to the causative
agent of AVM at concentrations which induced moderately severe lesions in
birds. These results agree with previous studies of mammalian susceptibility
which found no lesion formation in mice and swine following exposure to AVMpositive vegetation and coot tissues (Lewis-Weis et al., 2004; Rocke et al., 2005;
Birrenkott, unpubl. data).
While the mice did not develop characteristic AVM lesions in this study,
ten of nineteen mice exposed to either the crude AVM-positive extract or the
fractions produced from this extract developed unusual lesions localized to the
hippocampus. These lesions may have been an artifact of the fixative process,
although this conclusion is hard to fully accept due to the absence of lesions in the
control mice. However, it is also unlikely that if the lesions are real they would
be induced by all four fractions produced from the crude extract. The
fractionation procedure produced four fractions of widely varying polarity, with
the extremely non-polar hexanes fraction and the extremely polar particulate
fraction (which was only soluble in water and not methanol), as well as both
intermediate fractions, resulting in hippocampal lesion formation.
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The fractionation procedure did isolate the in vitro toxicity associated with
the extracts, as the MeCl2 fraction induced a significant increase of cells in G2/M
following a 4 h exposure. These results are consistent with those in Chapter 4
(Wiley, 2007), in which the MeCl2 fraction produced from vegetation collected
from Woodlake, North Carolina during an AVM epizootic induced a significant
cell cycle arrest. The Woodlake fractions were also tested by an in vivo chicken
bioassay to confirm toxicity, but histological brain analyses for that experiment
were inconclusive. Since the mice in the present study also did not develop
characteristic AVM lesions, it is not known whether the observed in vitro effects
in these studies are due to the AVM toxin or some other bioactive compound
associated with the extracts.
Despite the fact that mice in this study did not develop characteristic AVM
lesions, there is still a possibility that mammals could be affected by the causative
agent but are less sensitive than birds. The extract dosage used in this study was
based on that which produced lesions in mallards. The archived extract from the
mallard study was only sufficient to administer this dosage to the mice for two
weeks. It was thought that this time period would be sufficient, as several studies
have now shown that the onset of disease can occur within a two week time
period (Rocke et al., 2002; Wiley, 2007, Chapter 2, Chapter 3). However, the
dynamics of lesion onset are not yet understood, and it is possible that an acute
exposure could produce lesions if toxin concentrations are sufficient, but also that
lower concentrations given over a longer time period may also result in AVM.
Therefore, it is possible that a higher concentration of the extract or a longer
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exposure period would have resulted in AVM lesion formation. It is also possible
that while acute exposure to the AVM toxin may not result in the same pathology
in mammals as in birds, chronic exposure to the toxin may prove to be harmful in
some way.
While this study provides a better indication of mammalian susceptibility
to AVM than previous studies, it is not conclusive evidence that mammals are not
affected by the causative agent of AVM. Further study is needed to fully evaluate
the toxic potential of this disease for mammalian wildlife and humans. The
development of an extraction procedure for the toxin and work towards further
isolation of the toxin in crude extracts will provide tools for future research. If a
cleaner extract can be developed it could be administered to a mammalian model
by various routes (intravenous, intraperitoneal, and/or oral) at a wide range of
concentrations. It would also be wise to test the extract in acute and chronic
experiments and examine effects on various parameters in addition to lesion
formation, including full behavioral evaluations while the animals are live, as well
as histological evaluation of other tissues and biochemical analysis on blood
samples. Increasing the sample size per group beyond three animals and
processing the brain tissue by a different method would also be helpful in
evaluating the hippocampal lesions seen in this study.
The potential for this disease to impact mammalian wildlife and human
health is evident. Mammals such as raccoons and foxes have been documented as
consuming American coots (Fischer et al., 2006), and other herbivorous mammals
such as beavers are exposed through their diet. Humans consume waterfowl that
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are known to be affected by AVM, and the potential exposure is increased by the
fact that hunting season corresponds with AVM epizootics. While the evidence
so far suggests that mammals are not susceptible to this disease, further study is
needed to more fully evaluate the potential effects of the AVM agent on these
species.
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CONCLUSIONS

The major objectives of this dissertation were to develop extraction
methods for isolating the AVM toxin from vegetative samples and to develop an
in vitro, cell-based bioassay for detection and study of the toxin. The AVM toxin
was successfully extracted from vegetative samples and methanol was shown to
be a suitable solvent for this procedure. The AVM toxin is probably moderately
polar and water-soluble. It is stable at -20°C for at least one year and is not
extremely volatile. Further fractionation of the crude extract will be necessary to
provide a more accurate and detailed description of the physical properties. I
attempted to further fractionate the crude extract, but unfortunately the presence
of the AVM toxin in those fractions could not be confirmed due to inconclusive
results from the in vivo bioassays.
In vitro toxicity associated with the extracts for AVM-positive sites
revealed that the toxin may arrest the cell cycle of C6 glioma cells and this effect
may be an efficient measure of detecting the AVM toxin in environmental
samples. However, this effect cannot yet be attributed to the AVM toxin, as the
extracts tested were in crude form and may have contained other bioactive
substances. The toxic activity associated with cell cycle arrest was further
isolated by fractionation of the crude extracts, but could not be confirmed as the
AVM toxin due to the inconclusive in vivo results.

In vivo bioassays remain the only method of confirming the AVM toxin in
environmental samples. The cell cycle assay may provide a suitable in vitro assay
for toxin detection, but it must first be validated through the use of parallel in vivo
studies. The challenges that occur with in vivo studies, including the choice of an
appropriate animal model and time period of exposure, must be resolved before a
successful in vitro method can be confirmed. Mallards appear to be the most
reliable model, but require an extensive amount of sample material to conduct the
assays and are also difficult to acquire. Chickens are more readily available, and
young chicks require much less sample material, but it is unclear whether they are
as susceptible to the AVM agent as mallards. A parallel study using both
mallards and chicks would be useful in determining the susceptibility differences
of these species. The time period of exposure necessary to induce toxicity is also
still unknown, but it is recommended that subsequent in vivo assays include at
least a four-week exposure period until this variable is more fully understood.
The presence of AVM-affected birds on a reservoir is not sufficient
evidence that the AVM toxin will be present in collected vegetation. Therefore,
vegetation collected for future toxin isolation procedures should be tested by an in
vivo bioassay to confirm AVM toxin presence prior to conducting toxin
extraction. While this will add an extra step in the research process, it will
prevent the waste of time and resources in preparing extracts of vegetation that
may not be toxic. It is also recommended that vegetation be collected as soon as
AVM-affected birds are documented on the reservoirs to have a better chance of
collecting material containing the active toxin.
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The issue of mammalian susceptibility is not fully resolved. Mice exposed
to the AVM toxin by gavage in this research did not develop characteristic AVM
lesions, providing further evidence that mammals are not susceptible. However,
unusual hippocampal lesions were present in several mice exposed to these
extracts. While these lesions may be artifactual, additional experiments are
needed to further evaluate a possible causative link between the AVM toxin and
the presence of these lesions.
AVM continues to impact eagle and coot populations in the Southeast.
Management and mitigation of AVM depends upon continued research efforts
towards identifying the source of this disease. The extraction methods developed
here, as well as the preliminary work at identifying an in vitro model for AVM,
will greatly benefit the continued search for the causative agent. Further efforts at
isolating the toxic agent and validating the in vitro assay are needed to continue
this valuable line of research.
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